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Abstract 
 
Human history is also a history of the ceaseless fight against various diseases, especially 
those caused by pathogenic infections. Both scientists and pharmaceutical companies have been 
dedicated in developing antimicrobial compounds to combat the micro-enemies. Despite the 
efforts, the resistant strains keep emerging with the introduction of new therapeutic compounds, 
which implies an urgent need for compounds with modified or novel scaffolds to overcome the 
resistance. One good source of antimicrobial compound discovery is natural products. And 
research on their biosynthesis is of great importance in understanding and also utilizing nature’s 
tools to create bioactive compounds and variants. 
One major class of bioactive natural products is ribosomally synthesized and post-
translationally modified peptides (RiPPs). Precursor peptides and tailoring enzymes for post-
translational modifications (PTMs) are encoded in the same gene cluster, which is efficient in 
producing peptide variants providing different precursor sequences. The peptides are first 
synthesized on ribosomes and then undergo extensive modifications by the tailoring enzymes to 
generate active, rigid and stable products. Elucidation of the biosynthetic process, especially the 
enzymatic mechanisms in PTMs provide the guidelines of engineering either the peptides or the 
tailoring enzymes to produce more effective and stable RiPP variants or derivatives. 
Lanthipeptides are RiPPs bearing characteristic lanthionine (Lan) and/or methyllanthionine 
(MeLan) bridges. Many of them display potent antimicrobial activities, such as the class I 
lanthipeptides nisin and microbisporicin. However, the mechanism of one key step in their 
biosynthesis – dehydration – was still mysterious, until recently researchers in Wilfred van der 
Donk group found class I lanthipeptide dehydratase catalyzes the reaction in a tRNA-dependent 
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manner. To understand the structural basis of dehydration reaction, I determined the crystal 
structures of two class I lantibiotic dehydratases involved in the biosynthesis of nisin and 
microbisporicin, respectively. The structures supported the proposed two-step mechanism of 
dehydration reaction, illustrated the decisive factors for peptide substrate recognition, and 
provided clues on the tRNA-binding site based on a docking model. 
Plantazolicin is a linear azol(ine)-containing peptide (LAP) that specifically inhibits the 
growth of anthrax causing pathogen Bacillus anthracis. It contains two patches of thiazole and 
(methyl)oxazole/methloxazoline rings that endow its rigidity. It has an Nα, Nα-dimethyl-arginine 
at the N-terminus, which is critical for the antibacterial activity. The N-methyltransferase 
responsible for this modification in the gene cluster is very selective to thiazole/(methyl)oxazole 
substrates with an N-terminal arginine. By studying its crystal structures in complex with 
truncated substrate analogs as well as steady-state kinetics, I demonstrated the determinants of 
the substrate specificity and key residues involved in interacting with substrate. 
Cyanobactins are a group of small cyclic RiPPs produced by symbiotic or asymbiotic 
cyanobacteria. They contain rigid thiazoles and/or (methyl)oxazoles similar to LAP and 
additional head-to-tail cyclization on backbone to decrease its flexibility and susceptibility to 
proteases. Many cyanobactins are subsequently decorated with isoprenoid groups on Tyr, Ser or 
Thr residues for improved hydrophobicity. To understand the substrate requirements for 
cyanobactin prenyltransferases, I performed structural study of selected cyanobactin 
prenyltransferases with isoprenoid donor and various acceptors to illustrate the substrate 
selectivity. Examination of the substrate spectrum further supported the proposed substrate 
requirements based on structural information. 
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Chapter 1    Introduction 
 
A large part of human history is about diseases, especially the infectious diseases. 3000-year-
old Egyptian mummies have had smallpox detected in them (Brachman, 2003). Ancient Greek 
and Egyptian documented epidemics of smallpox, leprosy and tuberculosis (Watts, 1997). It was 
considered that Greek physician Hippocrates first described many diseases and symptoms, and 
believed the dissemination of disease was through airs, waters and places (Brachman, 2003; 
Shulman, 2004). This belief survived and from it, the miasmas theory derived. Poisonous vapors 
were thought to be the origin of epidemic infectious diseases and the air contaminated by them 
was the vehicle of transmission (Karamanou, Panayiotakopoulos, Tsoucalas, Kousoulis, & 
Androutsos, 2012). This concept was held for centuries until Girolamo Fracastoro in the 1500s 
brought up the germ theory– infection was caused by transferable seed-like beings through three 
routes. However, this theory didn’t become mainstream, even if the discovery of the microscope 
by Anton van Leeuwenhoek in 1600s inspired physicians and scientists to make connections 
between infections and microorganisms. In 1800s, Louis Pasteur and Robert Koch’s researches 
eventually persuaded the majority that the microorganisms were not generated spontaneously 
and disease could be caused by a specific microorganism (Brachman, 2003; Karamanou, 
Panayiotakopoulos, Tsoucalas, Kousoulis, & Androutsos, 2012; Casanova & Abel, 2013). Since 
then, this remains as the dominant theory for infectious diseases. 
Confronted with these pathogenic microorganisms, human beings fought back using two 
main approaches. The first is the development and utilization of vaccines. Vaccines resemble the 
pathogenic microorganisms and train the immune systems to recognize and destroy the real 
pathogens once they invade the body. Since the very first vaccination performed by Edward 
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Jenner to prevent smallpox in 1796, a number of successful vaccines have been developed and 
introduced to the public in the last two centuries, such as those against diphtheria, measles and 
polio (Stern & Markel, 2005). The second practice is to treat the pathogens with antimicrobials 
once the infection occurs. The concept of antimicrobial was introduced in 1900s, much later than 
vaccine. But the exposure to antimicrobial could be dated back to ancient Egypt, where the traces 
of tetracycline from dietary materials were detected in human skeletal. Another type of exposure 
was possibly through the natural compounds in traditional medicines (Aminov, 2010). Human 
have a long history of using natural resources such as plants to cure diseases. It was reported the 
Neanderthals in 60,000 years ago might have noticed the medicinal properties of plants (Solecki, 
1975). Before the modern medicine emerged, traditional medicines from natural sources have 
flourished in both Occidental and Oriental countries. Nowadays, more and more natural 
compounds were proved to be the active components of these traditional remedies. The most 
famous example is the antimalarial drug artemisinin, extracted from Artemisia plants, which 
have been used as herbal remedies in China for thousands of years (Cui & Su, 2009). 
The modern antibiotic era began in early 1900s. German physician and scientist Paul Ehrlich 
proposed and popularized the idea of “magic bullet”– an ideal therapeutic agent that selectively 
act on pathogens but not the host. His laboratory synthesized hundreds of organoarsenic 
compounds for systematic screening in syphilis-infected rabbits and discovered Salvarsan, one of 
the most prescribed drugs (Aminov, 2010). Later, this method also led to the discovery of 
Prontosil, the prototype of all sulfa drugs. This primary version of a screen program was 
improved into the combinatorial chemistry and high-throughput screen in 1990s, becoming one 
of the most important strategies in drug discovery process in pharmaceutical companies. 
Alexandar Fleming discovered the very first natural antimicrobial compound penicillin in 1928 
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and described its isolation from Penicillium mold and potential use (Fernandes, 2006; Aminov, 
2010). The purification of penicillin opened the door to the golden era of antibiotic discovery and 
in the following decades a plethora of renowned antimicrobials were identified from massive 
screening of antimicrobial-producing microorganisms, such as the renowned vancomycin, 
erythromycin and teichoplanin. By 1990, around 80% of the drugs were natural products or their 
analogs (Li & Vederas, 2009). However, this success didn’t last long because of the repeated 
discovery of the existing compounds. Many pharmaceutical companies then switched to the 
small-molecule libraries and high-throughput screening, which didn’t give the expected returns, 
though. 
Thanks to antimicrobials, millions have been cured from infectious diseases and life 
expectance is greatly lengthened today compared with early 1900s. But as a consequence of 
using antimicrobials in prescription and food industry, the new global problem now is the 
reemergence of infections from multi-drug resistant microorganisms. The antibiotic resistant 
genes such as β-lactamases were suggested present in plasmids for millions of years but the 
large-scale production and utilization of antibiotics exerted a strong selection pressure on them 
(Aminov, 2009). The horizontal transfer of these genes became the main method of acquiring 
antibiotic resistance for microorganisms with mutation-driven resistance happening mainly in in-
host evolution. It is reported in U.S. at least 2 million people acquire infections with resistant 
bacteria each year and at least 23,000 people die from them (U.S. Centers for Disease Control 
and Prevention (CDC), 2013). Besides regulation on antimicrobial usage and prevention of 
infections, it is still urgent to improve old antimicrobials and discover novel antimicrobials to 
overcome resistance. One strategy is to generate analogs of old effective natural compounds 
either through semisynthesis or combinatorial biosynthesis (Li & Vederas, 2009; Bachmann, 
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Van Lanen, & Baltz, 2014). For instance, the large modular polyketide or nonribosomal peptide 
synthases provide a promising flexible assembly line for biochemical engineers to achieve 
increased substrate promiscuity, novel combinations and expanded product profile. A recent 
example is the heterologous expression of tailored erythromycin synthases to produce chiral 
pairs of deoxysugar analogs, of which, several demonstrated bioactivity against an erythromycin-
resistant Bacillus subtilis strain (Zhang, Li, Fang, & Pfeifer, 2015). A second strategy is to 
analyze the structure of active compounds and expand the small-molecule libraries to cover more 
biologically relevant chemical space for high-throughput screening (Harvey, Edrada-Ebel, & 
Quinn, 2015). Pharmaceutical companies have designed natural-product derived or inspired 
chemical libraries to incorporate in the lead-like properties (Pascolutti & Quinn, 2014). And the 
selection of screenings containing natural products significantly increased the number of hits 
(Sukuru, et al., 2009). A third approach is to turn back to nature and search for new 
antimicrobials. One challenge is to improve the techniques of high-throughput screening for 
natural-product-based collections. Extractions from natural sources are complicated and the 
effect on the biological target is thus complex and unpredictable. For example, the effective 
components may be present at too low concentrations or multiple components may act 
synergistically. Various pre-fractionation strategies and sensitive NMR techniques have been 
developed to reduce the complexity and address the structure-solving problem (Harvey, Edrada-
Ebel, & Quinn, 2015). On the other hand, only a small proportion of organisms in a limited 
variety of ecological niches have been screened for bioactive compounds, mainly the soil-
dwelling Actinomyces. It is worth expanding to other environments such as marine species, 
anaerobic bacteria and many more uncultured organisms. However, the problem is, even for the 
species that can be cultured under natural or laboratory growth conditions, a lot of these natural 
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products won’t be produced despite the detection of genes encoding the biosynthetic machinery. 
For example, in Streptomyces spp., it has been shown that the antibiotic expression is regulated 
by a quorum-sensing system similar to the well-studied LuxI/LuxR system in Vibrio fisheri. A 
group of signaling molecules, γ-butyrolactones, are synthesized and then sensed by other cells, or 
by other Streptomyces species to induce morphological change as well as antibiotic production 
(Takano, 2006; Aminov, 2009). Although it is possible to explore every feasible growth 
condition to induce production, the discovery process would be largely impeded without 
exploiting the genome sequencing and the genome mining approach (Bachmann, Van Lanen, & 
Baltz, 2014). 
With the completion of the Streptomyces coelicolor A3(2) sequencing project, researchers 
started to realize that the genome of this microbe encodes more natural-product-like biosynthetic 
pathways than the products previously detected (Bentley, et al., 2002). The increasing number of 
sequenced genomes in the database and better understanding of the genetics and enzymology of 
the natural products biosynthesis have significantly facilitated the identification and annotation 
of the biosynthetic gene clusters and the prediction of pathways and products in the last two 
decades (Fischbach & Walsh, 2006). Groups have been utilizing various strategies (for example, 
searching for typical gene structures and signature tailoring enzymes) to discover biosynthetic 
gene clusters from various sources, including actinobacteria (Doroghazi, et al., 2014), 
cyanobacteria (Leikoski, et al., 2013; Calteau, et al., 2014), anaerobic bacteria (Letzel, Pidot, & 
Hertweck, 2014), fungi (Khaldi, et al., 2010) and environmental DNA (Reddy, Kallifidas, Kim, 
Charlop-Powers, Feng, & Brady, 2012; Owen, et al., 2015). Bioinformatic tools (for example, 
antiSMASH (Weber, et al., 2015)), genetic engineering methods and sensitive analytical 
methods were also developed to speed up the identification and structural elucidation processes, 
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particularly for ribosomally-synthesized and post-translationally modified peptides (RiPPs), 
polyketides and nonribosomal peptides. The biosynthesis of both polyketides and nonribosomal 
are similar to fatty acid synthesis and carried out by multi-domain enzymes or enzyme 
complexes with small molecules as building blocks. In contrast, the biosynthesis of RiPPs starts 
with relatively large peptides translated on ribosomes. 
 
RiPPs 
In most cases, all the components necessary for RiPP biosynthesis are encoded in the same 
gene cluster, including the substrate peptide(s), all the modifying enzymes and protease for 
cleaving extra flanking sequences. In many instances, there are also genes for regulatory proteins 
and immunity proteins, which tune the expression level of the genes in the cluster and protect the 
producers from the potential damage caused by mature products. Transporters could also be 
included for exporting the mature peptides out of the cell. Under proper conditions, the gene 
encoding the peptide is initially transcribed and translated to precursor peptide, usually 20-110 
residues in length. The precursor peptide typically contains two segments: the N-terminal leader 
peptide and the C-terminal core peptide. Leader peptide is required for recognition by many 
tailoring enzymes and for export and the core peptide is where all the post-translational 
modifications take place. In some classes of RiPPs, an extra recognition sequence flanks the C-
terminus of the core peptide and is essential for excision and cyclization reactions (Arnison, et 
al., 2013). The tailoring enzymes encoded in the same gene cluster process the precursor peptide 
by installing various functional motifs, such as dehydrated amino acids, heterocycles, halogens, 
sugar moieties, and disulfide bonds. These modifications endow the substrate peptides with 
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structural rigidity, proteolytic stability and target-binding properties. The leader peptide is 
hydrolyzed afterwards and the mature peptide is secreted out of the cell (Fig. 1.1). 
A structural biology approach in elucidating RiPP biosynthesis is of considerable value in the 
sense that structural information on the enzyme-substrate interactions not only supports or 
further details the reaction mechanism but also provides the rationale for engineering the 
biosynthetic system. RiPPs possess attractive properties as drug candidates but are generally hard 
for total chemical synthesis. Given that natural variants occur in RiPP biosynthesis, research on 
the substrate tolerance of the machinery is crucial in generating more unnatural variants for 
bioactivity assessment. As an essential complement to the codon reprogramming experiments of 
the precursor peptide, structure study on the modifying enzymes illustrates what elements are 
necessary for substrate recognition and efficient turnover, and how much change on either 
substrate or enzyme could be tolerated to achieve balance in efficient substrate processing and 
expected product diversity. 
As mentioned above, the biosynthetic features of RiPPs provide a good platform for 
obtaining unnatural novel variants by designing new precursor peptides for the enzymes. 
Numerous studies on the RiPP biosynthetic machinery from various classes showed that the 
tailoring enzymes are quite tolerant on the peptide substrates and thus rational design of the 
peptides was attempted. A collection of RiPP variants with natural or unnatural amino acids 
incorporated were successfully produced through either heterologous expression of the gene 
cluster or simply one-pot in vitro enzymatic reactions, which further confirmed the potential of 
RiPPs as a reservoir for drug discovery (Li, Zhang, & Kelly, 2011; Pan & Link, 2011; Tianero, 
Donia, Young, Schultz, & Schmidt, 2012; Deane, Melby, Molohon, Susarrey, & Mitchell, 2013; 
Sardar, Lin, & Schmidt, 2015). 
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RiPPs have a wide variety of bioactivities, inclusing antimicrobial, antifungal, antiviral, 
anticancer, and cytotoxic. The bioactivity is believed to endow producer strains with the growth 
advantage by killing or inhibiting the competing microbes and this free gift from nature turns out 
to be a powerful tool for human beings to fight against diseases (Nolan & Walsh, 2009). The 
bacteriocin glycocin F secreted by Lactobacillus plantarum KW30 has been shown to inhibit the 
growth of a related Lactobacillus strain (Stepper, et al., 2011) and a panel of strains in the genera 
Streptococcus, Enterococcus and Bacillus. Lanthipeptides are generally active against Gram-
positive bacteria. The pinensins produced by Gram-negative bacterium Chitinophaga pinensis 
are the first lanthipeptides that exhibited significant inhibitory activity against filamentous fungi 
and yeasts, but weak antibacterial activity (Mohr, et al., 2015). Lanthipeptide labrynthopeptin A1 
potently inhibit the entry of HIV and HSV to cells and block the viral cell-cell transmission with 
no significantly induced inflammation response (Férir, et al., 2013). Lanthipeptide cytolysin 
produced by Enterococus faecalis species display hemolytic activity and enhance enterococcal 
virulence in pathogenic infections (Coburn & Gilmore, 2003). The cyclic cyanobactins also 
demonstrate antibacterial, antiviral and anticancer activities. Some are highly cytotoxic against 
human cancer cell lines and others show inhibition to the drug efflux system (Houssen & Jaspars, 
2010). 
Based on structural characteristics of the mature peptides and the biosynthetic machinery, 
RiPPs can be further grouped into different classes. They feature different types of post-
translational modifications, yet each type of modifications is not solely found in one specific 
class (Fig. 1.2). For example, the dehydration reaction on Ser/Thr residue is not exclusively used 
in lanthipeptides biosynthesis to prime the formation of thioether linkages. It is also a common 
strategy for linaridins and thiopeptides to obtain dehydrated amino acids. The azoles in 
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thiopeptides are also found in linear azol(in)e-containing peptides and cyanobactins, whereas the 
mechanisms of heterocyclization reactions and the compositions of the biosynthetic machinery 
differ from one another. Another example is the generation of head-to-tail macrocycle in 
cyanobactins and orbitides biosynthesis through excision of the C-terminal sequence followed by 
macrocyclation. Although the two proteases are quite distinct from each other, they utilize the 
same catalytic residues and achieve the same result. Here, I would like to describe more of the 
structural characteristics and biosynthetic pathways on lanthipeptides, linear azol(in)e-containing 
peptides and cyanobactins, on which my thesis research focused. 
 
Lanthipeptides 
Lanthipeptides are ribosomal peptides containing characteristic meso-lanthionine (Lan) or 
(2S,3S,6R)-3-methyllanthionine (MeLan) crosslinks. Lan is composed of two alanines linked by 
sulfur on β carbons, forming a thioether linkage; MeLan has one more methyl group on the β 
carbon of one of the alanines (Fig. 1.3 A). Lan residue was first isolated in 1941 (Horn, Jones, & 
Ringel, 1941), but the first lanthipeptide nisin was described in 1928 (Rogers, 1928) with its 
structure determined in 1971 (Gross & Morell, 1971). The Lan and MeLan are introduced by two 
reactions: dehydration and cyclization. They could be catalyzed by one synthetase or by separate 
dehydratase and cyclase. The Ser and Thr residues in the core peptide are first dehydrated to 
form 2,3-didehydroalanine (Dha) and (Z)-2,3-didehydrobutyrine (Dhb), respectively. The α,β-
double bond is subsequently attacked by the side chain of Cys to generate an enolate structure 
and protonation of the enolate produces the Lan or the MeLan. In some lanthipeptides, the 
enolate further attacks a Dha, resulting in the labionin (Lab) structure (Fig. 1.3 A) (Knerr & van 
der Donk, 2012; Arnison, et al., 2013). Lanthipeptides with antibiotic activity are termed 
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lantibiotics (Kellner, et al., 1988). Traditionally lantibiotics are discovered from Gram-positive 
producers and active against Gram-positive bacteria such as drug-resistant Staphylococi and 
Enterococci. The mechanism of action is believed to inhibit cell wall biosynthesis by 
sequestering precursor molecules and disrupt membrane integrity through pore formation. 
Recently, the genome mining projects have identified biosynthetic gene clusters from Gram-
negative bacteria (Li, et al., 2010; Singh & Sareen, 2014) and the activity spectrum is also 
broadened to cytotoxicity and antifungal activity. 
Lanthipeptides are categorized into four classes based on the enzymatic mechanisms of 
installing Lan/MeLan (Fig. 1.3 B). For class I lanthipeptides, two separate enzymes, dehydratase 
LanB and cyclase LanC, are responsible for catalyzing the formation of thioether crosslinks. 
LanB (Fig. 1.3 B) proteins usually contain around 1,000 amino acids and share no homology 
with any other known proteins. It was postulated previously that LanB dehydration activity 
involves the phosphorylation of the Ser/Thr side chains. The actual mechanism of dehydration 
reaction remained mysterious for many years until Garg et al. observed glutamylated peptide 
intermediates instead of phosphorylated intermediates in in vitro reconstitution study when using 
a LanB mutant deficient in elimination reaction (Garg, Salazar-Ocampo, & van der Donk, 2013). 
Further investigation showed LanB activates the side-chain hydroxyl groups of Ser and Thr by 
transferring the glutamyl group from Glu-tRNAGlu to them and subsequently eliminates it 
together with the α proton abstraction to generate Dha and Dhb (Ortega, Hao, Zhang, Walker, & 
van der Donk, 2015). LanC proteins are around 400 residues in length and share 20-30% 
sequence identity across the family (Knerr & van der Donk, 2012). The mechanism and structure 
study of the LanC enzyme in nisin biosynthesis revealed that the zinc ligand coordinated by the 
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Cys-Cys-His triad activates the thiol group of the substrate Cys to facilitate the nucleophilic 
attack onto Dha and Dhb (Li, Yu, Brunzelle, Moll, van der Donk, & Nair, 2006). 
For class II lanthipeptides, the dehydration and cyclization are catalyzed by a bifunctional 
enzyme LanM. LanM contains an N-terminal dehydration domain, with no homology with LanB, 
and a C-terminal LanC-like cyclization domain, with conserved zinc-binding ligands (Fig. 1.3 B). 
Mechanistic studies of various LanMs showed both dehydration and cyclization are leader 
peptide dependent whereas the activity of the each domain doesn’t require the presence of the 
other. Dehydration is adenosine triphosphate (ATP) and magnesium (Mg2+) dependent; 
cyclization is zinc dependent as predicted. Further dissection of the dehydration reaction 
revealed the phosphorylation of Ser and Thr side chains and the ADP-dependent phosphate 
elimination (Xie, Miller, Chatterjee, Averin, Kelleher, & van der Donk, 2004; Chatterjee, et al., 
2005; Li, et al., 2010; Dong, Tang, Lukk, Yu, Nair, & van der Donk, 2015). Despite the 
intertwined dehydration and cyclization, the directionality of each reaction type has been proved 
consistent for one LanM, but could be either N-to-C or C-to-N for different LanMs (Lee, Ihnken, 
You, McClerren, van der Donk, & Kelleher, 2009; Mukherjee & van der Donk, 2014). The first 
structure of a LanM protein revealed an unexpected lipid kinase-like dehydratase domain and a 
predicted NisC-like cyclization domain, with peptide-binding grooves proposed in each of them. 
Compared with lipid kinase, the dehydratase domain connects the conserved secondary elements 
in a noncanonical way with the phosphorylation site and elimination site adjacent to each other. 
The majority of the class III lanthipeptides contains the two-ring Lab structures besides Lan 
crosslinks (Meindl, et al., 2010). The polycycles are installed by a multifunctional synthetase 
LanKC, also in a leader peptide dependent manner (Müller, Ensle, Krawczyk, & Süssmuth, 2011; 
Wang & van der Donk, 2012). LabKC contains N-terminal pSer/pThr lyase domain, a Ser/Thr 
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kinase domain and C-terminal cyclase domain (Fig. 1.3 B). The precursor peptide is first 
phosphorylated on the kinase domain and then phosphate is eliminated by the lyase domain to 
generate dehydrated intermediate. Compared to LanMs, the kinase domain of LanKC displays 
relaxed phosphate donor selectivity. Some LanKCs accept all NTPs and dNTPs as cofactor while 
others prefer certain types (Völler, Krawczyk, Pesic, Krawczyk, Nachtigall, & Süssmuth, 2012; 
Wang & van der Donk, 2012; Krawczyk, Völler, Völler, Ensle, & Süssmuth, 2012). The 
corresponding NDPs and dNDPs are not required for the lyase domain to eliminate phosphate in 
contrast to LanMs. Interestingly, the cyclase domain harbors no zinc-binding residues and the 
cyclization reaction towards Lan or Lab works with no need for energy or any metal. The 
directionality of the reactions is believed C-to-N and the deficiency in the C-terminal Lab ring 
formation completely abolish the N-terminal ring cyclization (Krawczyk, Ensle, Müller, & 
Süssmuth, 2012; Wang & van der Donk, 2012). 
The founding member of class IV lanthipeptides was the putative lantibiotic venezuelin 
produced by a cryptic gene cluster in Streptomyces venezuelae. The predicted synthetase LanL 
successfully catalyzed in vitro dehydration and cyclization reaction on the recombinantly 
expressed peptide substrate with the addition of ATP and Mg2+ (Goto, Li, Claesen, Shi, Bibb, & 
van der Donk, 2010). Protein sequence analysis of LanL showed a domain organization similar 
to LanKC and the three reactions – phosphorylation, elimination and cyclization – were readily 
assigned to each domain through biochemical studies with truncated enzymes (Goto, Okesli, & 
van der Donk, 2011). One obvious distinction from LanKC is that the cyclase domain in LanL 
retains the zinc-binding ligands conserved in LanC and LanM. Thus the cyclase activity is 
believed to be zinc dependent. 
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The classic example of lanthipeptide is nisin produced by Lactococcus lactis, the longest-
known lanthipeptide. It serves as the model system for studying the mechanisms and structures 
of the biosynthetic enzymes. A recent addition to class I lanthipeptide is microbisporicin 
produced by Microbispora coralina, which displayed potent activity against drug-resistant 
Gram-positive bacteria comparable to nisin. In Chapter 2, I describe more about the their 
structure features and biosynthetic pathways. I also present the structure studies on the LanB 
enzymes involved in nisin and microbisporicin biosynthesis. LanB has similar molecular weight 
with other lanthipeptide synthetases but conducts only dehydration reaction. It is intriguing to 
understand how the structure elements are organized, how LanB recognizes its substrate and how 
it uses a less prevalent resource Glu-tRNAGlu rather than ATP to achieve the two-step 
dehydration reaction. 
 
Linear azol(in)e-containing peptides 
The very first linear azol(in)e-containing peptide (LAP) discovered is the cell-associated 
hemolysin streptolysin S (SLS) described in 1938 (Todd, 1938). Although it has been confirmed 
as a LAP since the discovery of its biosynthetic gene cluster and preliminary functional 
inspection of the proposed biosynthetic enzymes, the structure of SLS is still unknown (Mitchell, 
et al., 2009). The extensive and elaborate investigation of LAP synthetase started in 1990s, when 
a comprehensive study on the installation of azole rings in microcin B17 was published in 
Science (Li, Milne, Madison, Kolter, & Walsh, 1996). Later on, a growing number of gene 
clusters similar to microcin B17 were identified through bioinformatic study (Lee, et al., 2008; 
Melby, Nard, & Mitchell, 2011) and the enzymatic mechanisms on LAP biosynthesis were 
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unveiled gradually through further examination of the microcin B17 system or other 
representative ones. 
A typical LAP gene cluster encodes the precursor peptide A, the azole installing complex B, 
C and D, protease and transporters (Fig. 1.4 A). Some clusters also encode other modifying 
enzymes and auxiliary apparatus such as transcription regulator and immunity protein. At first, 
the precursor peptide is as well transcribed on ribosome. Then the azole rings are installed by the 
BCD complex, but the function assignment of each protein in the complex took over a decade. 
The B protein (McbC for microcin B17) was first confirmed as a flavin mononucleotide (FMN)-
dependent dehydrogenase to oxidize azolines to azoles (Li, Milne, Madison, Kolter, & Walsh, 
1996; Milne, et al., 1999) (Fig. 1.4 B). From primary sequence analysis and in vitro 
reconstitution of microcin B17 synthetase, C protein (McbB) was initially perceived to be 
catalytically active in azoline ring formation and D protein was proposed for substrate 
recognition. Additional attempts on either decoupling the heterocyclization and dehydrogenation 
or dissecting the former reaction in microcin B17 biosynthesis was in vain since omitting any of 
the three components resulted in a completely dead complex for precursor processing (Milne, et 
al., 1999). The roles of C and D protein became clear when the BalhCD system from Bacillus sp. 
Al Hakam was successfully reconstituted in vitro (Melby, Dunbar, Trinh, & Mitchell, 2012). 
Unlike the McbBCD, the heterocyclization and dehydrogenation in Balh system are readily 
independent of each other although the trimeric complex formed is as tight as McbBCD (Dunbar, 
Melby, & Mitchell, 2012; Melby, Li, & Mitchell, 2014). Further study revealed that the D 
protein alone is enough to catalyze azoline ring formation and ATP is consumed 
stoichiometrically to activate the substrate amide backbone, not for activating the enzyme or 
energizing the substrate displacement. The side chain hydroxyl of Ser/Thr or the thiol of Cys first 
	   15	  
gets deprotonated and attack the carbonyl carbon of the preceding amide bond, forming a 
hemiorthoamide intermediate. The resulting nucleophilic oxygen of the tetrahedral structure 
attacks the γ phosphate of ATP to form phosphorylated intermediate. The subsequent elimination 
of the phosphate generates an azoline ring (Dunbar, Melby, & Mitchell, 2012; Dunbar & 
Mitchell, 2013) (Fig. 1.4 B). The heterocyclase D processes Cys much more efficient than 
Ser/Thr and also demonstrates regioselectivity (Belshaw, Roy, Kelleher, & Walsh, 1998; Melby, 
Dunbar, Trinh, & Mitchell, 2012; Bentley, et al., 2002). The protein C, however, is not 
redundant. It binds heterocyclase D, regulates ATP binding and ensures proper catalysis 
(Dunbar, Chekan, Cox, Burkhart, Nair, & Mitchell, 2014). The importance of leader peptide has 
been demonstrated through mutational studies in different LAP systems and protein C is 
demonstrated to provide leader-binding site (Roy, Kim, Baleja, & Walsh, 1998; Mitchell, et al., 
2009; Dunbar, Chekan, Cox, Burkhart, Nair, & Mitchell, 2014). The directionality of both 
heterocyclization and dehydrogenation has been thoroughly studied and a general N-to-C or C-
to-N direction was observed (Kelleher, Hendrickson, & Walsh, 1999; Melby, Dunbar, Trinh, & 
Mitchell, 2012; Melby, Li, & Mitchell, 2014). The leader is then cleaved by a protease and the 
core peptide either undergoes more modifications or is exported as mature product. 
LAPs display a variety of bioactivities. Microcin B17 inhibits bacterial DNA gyrase (Vizán, 
Hernández-Chico, del Castillo, & Moreno, 1991), streptolysin S and clostridiolysin S are 
hemolytic (Todd, 1938; Gonzalez, et al., 2010), and plantazolicin produced by Bacillus 
amyloliquefaciens FZB42 is a narrow spectrum antibiotic specifically against closely related 
Bacilli (Scholz, et al., 2011). Plantazolicin (PZN) contains two polyazolic patches and apart from 
the presence of a non-oxidized methyloxazoline ring, it also has a Nα, Nα-dimethyl-arginine at N-
terminus (Kalyon, et al., 2011; Molohon, et al., 2011). This dimethylation is crucial for its 
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bioactivity since the desmethylPZN completely loses its ability to inhibit the growth of the 
anthrax-causing bacterium Bacillus anthracis (Molohon, et al., 2011). The methyl groups are 
installed by a S-adenosylmethionine (SAM)-dependent α-N-methyltransferase PznL and it works 
selectively on azole containing substrates (Lee, et al., 2013). In Chapter 3, I present my work on 
the structural study of two PznL homologs and explain the structural determinants for the 
substrate selectivity. A minimal substrate could also be proposed from structural information. I 
also present the kinetic analysis on peptide substrate analogs with both the wildtype enzyme and 
several mutants. 
 
Cyanobactins 
Cyanobactins are small cyclic peptide produced by free-living cyanobacteria or symbiotic 
ones within ascidians, with several recently discovered members with linear structures (Sivonen, 
Leikoski, Fewer, & Jokela, 2010; Leikoski, et al., 2013). The head-to-tail macrocyle typically 
contains six to ten amino acids with varying numbers and combinations of azoles and azolines. 
Some cyanobactins have additional decorations such as prenylation, methylation and disulfide 
bridge. The first discovered cyanobactins were ulicyclamide and ulithiacyclamide described in 
1980 (Ireland & Scheuer, 1980), and the latter showed high antitumor activity when tested with 
both leukemia cell lines and solid tumors (Houssen & Jaspars, 2010). The search for marine 
bioactive compounds in the following decades led to the discovery of more than a hundred 
cyanobactins. Their ribosomal origin became clear when the first cyanobactin gene cluster and 
biosynthetic pathway were described for patellamide in 2005 (Schmidt, et al., 2005). 
The cyanobactin precursor peptides and enzymes necessary for maturation are encoded in the 
same gene cluster. There are more than one precursor peptide gene E in the cluster and each 
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precursor peptide E has the potential to produce a variety of mature cyanobactins (Donia, Ravel, 
& Schmidt, 2008; Donia & Schmidt, 2011). The peptide E contains a N-terminal leader peptide, 
recognition sequence I (RSI), recognition sequence II (RSII) and core peptide, followed by 
recognition sequence III (RSIII); multiple repeats of RSII, core peptide and RSIII could occur 
with varied core sequence (Fig. 1.5 A). Compared with the hypervariable core peptide, other 
elements are relatively conserved/homologous, indicating their role in guiding correct post-
translational modifications (Donia, et al., 2006; Sardar, Pierce, McIntosh, & Schmidt, 2015). The 
precursor peptide first encounters the heterocyclase D and has thiazoline/(methyl)oxazoline rings 
installed in a C-to-N directionality with a mechanism similar to the D enzyme in LAP 
biosynthesis (McIntosh & Schmidt, 2010; McIntosh, Donia, & Schmidt, 2010; Koehnke J. , et 
al., 2013). The notable difference is the oxygen of hemiorthoamide tetrahedral intermediate 
attacks the α-phosphate of ATP instead of γ-phosphate to generate an adenylated intermediate, 
and then the AMP gets eliminated (Koehnke J. , et al., 2013; Koehnke, et al., 2015) (Fig. 1.5 B). 
Most D enzymes don’t distinguish Cys and Ser/Thr with the exception of TruD, which 
preferentially works on Cys (McIntosh & Schmidt, 2010; McIntosh, Donia, & Schmidt, 2010). 
The leader peptide was postulated to be necessary for heterocyclization based on the general rule 
of RiPP biosynthesis. However, both biochemical and structural studies suggested it is not the 
leader but the conserved RSI is indispensable for substrate recognition and productive binding 
(Koehnke J. , et al., 2013; Sardar, Pierce, McIntosh, & Schmidt, 2015; Koehnke, et al., 2015). Its 
β strand structure forms extensive hydrogen-bonding interaction with the β strand of a α+β 
domain in the D enzyme and this domain is therefore assigned as recognition sequence-binding 
domain. A universal leader peptide recognition motif was then proposed based on this example 
together with other RiPP enzyme-peptide complex structures (Koehnke, et al., 2015; Burkhart, 
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Hudson, Dunbar, & Mitchell, 2015). Next, the subtilisin-like serine protease A recognizes RSII 
and cuts the flanking sequence N-terminal to the core (Lee, McIntosh, Hathaway, & Schmidt, 
2009; Agarwal, Pierce, McIntosh, Schmidt, & Nair, 2012; Houssen, et al., 2012) (Fig. 1.5 A). A 
similar protease G recognizes RSIII and cuts the C-terminal flanking sequence and cyclize the 
core peptide (Donia, Ravel, & Schmidt, 2008) (Fig. 1.5 A). Not only the RSIII but also the 
restrained cyclic structure of the last residue in the core peptide is suggested to be critical for 
macrocyclization activity (McIntosh, Robertson, Agarwal, Nair, Bulaj, & Schmidt, 2010; 
Koehnke J. , et al., 2012). It is believed an acyl-enzyme intermediate is formed in the cyclase 
reaction as other serine proteases and the aminolysis outcompetes hydrolysis to promote cyclic 
product accumulation rather than its linear counterpart (Agarwal, Pierce, McIntosh, Schmidt, & 
Nair, 2012). To impose more restraints on the heterocycles, a FMN-dependent oxidase 
dehydrogenates the azoline rings to corresponding azoles, but limited research has been done on 
the details and the exact timing of the reaction remains unknown (Houssen, et al., 2014). In some 
cases, the core peptide undergoes more modifications, such as methylation by a SAM-dependent 
methyltransferase and prenylation by a dimethylallyl pyrophosphate (DMAPP)-dependent 
prenyltransferase F. To further assess the potential of this naturally occurred combinatorial 
library, researchers were able to design the sequences of the core peptide to build unnatural 
cyanobactin libraries either by heterologous expression or by in vitro one-pot enzymatic 
synthesis (Donia, et al., 2006; Donia, Ravel, & Schmidt, 2008; Tianero, Donia, Young, Schultz, 
& Schmidt, 2012; Houssen, et al., 2014; Ruffner, Schmidt, & Heemstra, 2015; Sardar, Lin, & 
Schmidt, 2015). 
Based on the gene organization in the operon(s), the cyanobactin gene clusters are classified 
into four genotypes (Donia & Schmidt, 2011) (Fig. 1.5 C). Genotype I is the most classic one 
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with protease A, heterocyclase D, prenyltransferase F, and protease G with the oxidase fused at 
N-terminus. Genotype II doesn’t contain heterocyclase and oxidase. Correspondingly, there is no 
RSI in precursor sequences in the precursor peptides and no heterocycles in the mature products. 
For proper cleavage of the C-terminal flanking sequence and macrocyclization, a proline appears 
as the last residue of core peptide. Genotype III contains every necessary enzyme as genotype I 
but with a standalone oxidase. Likewise, genotype IV also has the standalone oxidase while a 
methyltransferase is fused to protease G, indicating further decoration on the final products. 
Recent genome mining study suggested more types of gene organization such as the fusion of a 
methyltransferase with the protease A and the fusion of a methyltransferase with the 
prenyltransferase F (Leikoski, et al., 2013). Short linear cyanobactins were also discovered in 
this study. 
The prenyltransferase F is not essential in cyanobactin biosynthesis but the prenylation of the 
polar groups certainly increases the lipophilic properties of cyanobactins. The TruF in tru 
pathway selectively reverse-prenylates Ser/Thr side chains (Donia, Ravel, & Schmidt, 2008). 
The LynF in lyn pathway reverse-prenylates the hydroxyl group of Tyr and the subsequent 
nonenzymatic Claisen rearrangement results in a forward-prenylated product (McIntosh, Donia, 
Nair, & Schmidt, 2011). PagF and ThcF in pag ant thc pathways forward-prenylate the hydroxyl 
groups of Tyr in the peptide substrate. The PirF in pir pathway is unusual in the sense it doesn’t 
prenylates but geranylates the Tyr. In Chapter 4, I present structural studies on PagF and PirF 
and propose their substrate requirements. I also tested the substrate specificity of ThcF and PirF. 
The results show the cyanobactin prenyltransferases have broad substrate spectra and are 
potential tools to prenylate any peptide to increase peptide lipophilicity. 
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Figures 
 
 
 
Fig. 1.1    General biosynthetic pathway of RiPPs. The ribosomally synthesized precursor 
peptide contains core peptide for post-translational modifications. The N-terminal leader peptide 
and C-terminal recognition sequence guide tailoring enzymes to perform modifications 
accurately. After cleavage of the flanking sequences, the modified core is exported as mature 
peptide. 
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Fig. 1.2    Representative compounds from different RiPP classes. Nisin A is from lanthipeptide 
class; cypemycin is the first member discovered in linaridin class; plantazolicin is a linear 
azol(in)e-containing peptide; Micrococcin P1 is a thiopeptide; patellamide A is a representative 
cyanobactin; segetalin A is an orbitide. 
  
N
S
N
N
S
O
HN
NH
O
OH
S
N
S
N
O
HN
HO
HN
O
N
S
O
H
N S
N
OHN
OH
Micrococcin'P1
''(thiopeptide)
O
N
HO N N
S
NH HN
O
O
S
N N OH
N
O
Patellamide)A
(cyanobactin)
HN
O
H
N
NHO
O
NHN
O
O
HN O
H
N
Segetalin)A
)(orbitide)
N
NH
NHH2N
N
S
O
N
N
S
O
N
N
O H
N
O
O
N
H O
N
N
O
O
N
N
O
O
N
O
N
H
O
OH
!!!!!!!!!!!!!!!!!!!!Plantazolicin
(linear!azol(in)e/containing!peptide)
H2N
O
H
N O
HN
OHN
N
H
O
HN O
S
O
H
N S
O
N O
HN
HN
O
O
HN
NH2
NHO
S
N
H
OOHN
NH
O
O
H
N NH
O
S HN
O O
N
H
O
NH2
O
HN
NHO
S
HN
O
H2N
S
NHO
O
HN
HN O
S
O
N
H
O
HN
NHN
O
NH
HN
O
HO
Me
OHN
O
H
N
N
NH
N
H
OH
N
OOHO
H2N
!!!!!!!Nisin!A
(lanthipeptide)
N
H
N
O
O
N
H
H
N
O
N
H
O
H2N O
H
N
O
N
H
O H
N
O
O
N
H
H2N O
H
N
O
O
N
H O
H
N
HO O
N
H
H
N
O
O
N
H NH
O
N
H
O
SO
HN
O
H
N
O
N
O
N
H
O
N Cypmycin
(linaridin)
	   22	  
 
 
Fig. 1.3    A. Biosynthetic pathway to (Me)Lan and Lab formation. Ser and Thr are first 
dehydrated to form Dha and Dhb, respectively. Subsequent attack by the Cys side chain 
generates an enolate. Protonation of the enolate produces (Me)Lan. The further attack of the 
enolate to a Dha produces Lab. B. Four classes of lanthipeptides defined by the different 
biosynthetic machinery and the enzymatic mechanisms of installing (Me)Lan. 
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Fig. 1.4    A. A representative gene cluster of linear azol(in)e-containing peptide. It contains 
precursor peptide A, the cyclodehydratase (heterocyclase) D, a leader peptide-binding protein C, 
dehydrogenase B and transporters. B. Biosynthetic pathway to azole formation. Nucleophilic 
attack by the side chain of Ser/Thr/Cys onto the preceding carbonyl generates a hemiorthoamide 
intermediate. CD protein complex phosphorylates the intermediate to facilitate the elimination 
reaction rather than the cleavage of the amide bond. The resulting azoline is further oxidized by 
the FMN-dependent dehydrogenase B to generate azole. 
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Fig. 1.5    A. The general biosynthetic pathway of cyanobactins. The ribosomally translated 
precursor peptide contains multiple core peptides and RSs for enzyme recognition. The 
heterocyclase D recognizes RSI and catalyzes the formation of azolines from Ser/Thr/Cys. The 
N-terminal protease cleaves the N-terminal flanking sequence. The macrocyclase cleaves the C-
terminal flanking sequence and cyclize the modified core peptide. B. The biosynthetic pathway 
to azoline formation. The mechanism of azoline installation is similar to that of LAP 
biosynthesis. The side chain of Ser/Thr/Cys attacks the preceding carbonyl to generate a 
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hemiorthoamide intermediate. The intermediate is then adenylated instead of phosphorylated and 
elimination of AMP facilitates the azoline generation. C. General representation of four 
genotypes of cyanobactins. 
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Chapter 2    Structural Studies on the tRNA-Dependent Lantibiotic Dehydratases1 
 
2.1 Structural Study of Lantibiotic Dehydratase NisB in Nisin Biosynthesis 
 
Introduction 
Nisin, produced by Lactococcus lactis, is the longest known lantibiotic. Its antimicrobial 
activity against Gram-positive bacteria was first described in 1928 (Rogers, 1928). It was 
partially purified and analyzed in 1944 and its structure was determined in 1971 (Mattick & 
Hirsch, 1944; Gross & Morell, 1971). Although nisin has the potential as a therapeutic agent in 
pharmaceutical industry, so far its application is mainly in food industry to combat food-borne 
pathogens such as Listeria monocytogenes. Made by a food-grade organism, nisin has been used 
as a safe and effective food preservative for almost 50 years without any significant resistance 
developed. Due to its important industrial application, nisin has been intensively studied on 
every aspect, including its mode of action and biosynthesis. 
Nisin displays potent antibacterial activity against a wide range of Gram-positive bacteria 
and their spores, including multidrug-resistant Streptococcus pneumoniae, methicillin-resistant 
Staphylococcus aureus and vancomycin-resistant Enterococci (Severina, Severin, & Tomasz, 
1998). By binding to lipid II, the final intermediate to peptidoglycan biosynthesis, nisin exhibits 
its activity in two mechanisms: inhibiting cell wall synthesis and forming pores on cell 
membrane. The N-terminal A and B rings of nisin cage the pyrophosphate moiety of lipid II and 
block the access of transglycosylase. Thus lipid II is sequestered from cell wall synthesis at the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Part of this chapter is adapted from the following published article: 
 
Ortega, M. A., Hao, Y., Zhang, Q., Walker, M. C., van der Donk, W. A., & Nair, S. K. (2015). Structure and 
mechanism of the tRNA-dependent lantibiotic dehydratase NisB. Nature, 517 (7535), 509-512.	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cell division site. Nisin is also positioned in a transmembrane orientation by binding to lipid II 
and they form a hybrid pore in the membrane, disrupting membrane potential and causing efflux 
of metabolites and cessation of biosynthesis (Brotz, et al., 1998; Breukink, Wiedemann, van, 
Kuipers, Sahl, & de Kruijff, 1999; van Heusden, de Kruijff, & Breukink, 2002; Breukink, et al., 
2003; Hasper, de Kruijff, & Breukink, 2004; Hsu, et al., 2004; Hasper, et al., 2006). 
The identification and characterization of nisin biosynthetic gene cluster started in late 1980s, 
much later than its approval as a food additive (Buchman, Banerjee, & Hansen, 1988; Kaletta & 
Entian, 1989). The cluster contains genes for nisin biosynthesis and secretion: precursor gene 
NisA, dehydratase NisB, cyclase NisC, transporter NisT and protease NisP; it also contains 
immunity genes NisI and NisFEG, and regulatory genes NisRK (Kuipers, Beerthuyzen, Siezen, 
& de Vos, 1993; Qiao, et al., 1996) (Fig. 2.1 A). Nisin is synthesized ribosomally as a 57 amino 
acid precursor peptide, consisting of a 23-residue leader peptide and a 34-residue core peptide 
(Fig. 2.1 B). The presence of leader is crucial for the maturation enzymes to correctly process the 
core peptide, so that the 1 lanthionine (Lan), 4 methyllanthionines (MeLans), 1 dehydrobutyrine 
(Dhb) and 2 dehydroalanes (Dha) could be installed. NisB is responsible for dehydrating Ser/Thr 
to Dha/Dhb and NisC catalyzes the formation of thioether crosslinks between Cys and the 
Dha/Dhb, generating five intramolecular rings in the core region (Koponen, Tolonen, Qiao, 
Wahlstrom, Helin, & Saris, 2002) (Fig. 2.1 B). It was demonstrated that NisB and NisC form a 
multimeric membrane-associated complex with exporter NisT and that the dehydration and 
cyclization reactions intertwine (Siegers, Heinzmann, & Entian, 1996; Lubelski, Khusainov, & 
Kuipers, 2009), but the two enzymes are active independent of each other. The inactive mature 
nisin secreted by NisT is cleaved by the extracellular subtilisin-like Ser protease NisP to form 
active nisin (Qiao & Saris, 1996; van der Meer, Polman, Beerthuyzen, Siezen, Kuipers, & de 
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Vos, 1993) (Fig. 2.1 B). The producer cell is protected from its own product by the synergistic 
work of nisin-binding lipoprotein NisI and the ABC transporter NisFEG (Siegers & Entian, 
1995; Qiao, Immonen, Koponen, & Saris, 1995; Stein, Heinzmann, Solovieva, & Entian, 2003; 
Takala, Koponen, Qiao, & Saris, 2004). Nisin acts as an auto-inducer and control its production 
through the constitutively expressed two-component regulatory system. The system is composed 
of a sensor histidine kinase NisK and a response regulator NisR. NisK senses the extracellular 
mature nisin and activates the transcription activator NisR. The activated NisR next activates the 
transcription of nisin biosynthesis genes and immunity genes (Engelke, Gutowski-Eckel, Kiesau, 
Siegers, Hammelmann, & Entian, 1994; Kuipers, Beerthuyzen, de Ruyter, Luesink, & de Vos, 
1995; de Ruyter, Kuipers, Beerthuyzen, van Alen-Boerrigter, & de Vos, 1996). 
The biosynthesis of nisin was largely studied in vivo with genetically modified producers. 
This approach was very successful in tracking the cellular location of the biosynthetic 
machinery, in probing the transient or permanent interactions between the enzymes and between 
the enzyme and the substrate, and in evaluating the tolerance of the whole system to the 
mutations in either substrate or enzymes. Nevertheless the tightly coupled system also hindered 
the study of each step in detail, such as the cofactor requirements of the dehydration and 
cyclization. Thus in vitro reconstitution of each step is the preferential approach to decouple the 
intertwined dehydration and cyclization reactions and study the enzymatic mechanisms. The 
cyclization reaction was first successfully reconstituted with heterologously produced dehydrated 
nisin precursor and the crystal structure of NisC was solved with bound zinc, which coordinates 
the thiolate of Cys in NisA (Li, Yu, Brunzelle, Moll, van der Donk, & Nair, 2006). The in vitro 
study of NisB, however, was only limited to its affinity to the non-processed or processed 
precursor peptides, although much is known about the peptide residues required for recognition 
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and NisB relaxed substrate specificity through in vivo studies (Kluskens, et al., 2005; Rink, de 
Boef, Leenhouts, Driessen, Moll, & Kuipers, 2005; Rink, et al., 2007; Plat, Kluskens, Kuipers, 
Rink, & Moll, 2011; Mavaro, et al., 2011; Khusainov, Moll, & Kuipers, 2013). The first 
successful in vitro reconstitution of NisB activity was accomplished recently by adding E. coli 
cell extract to the reaction. Also alanine scanning of conserved residues identified mutants that 
produce peptide intermediates modified with multiple Glu through ester bond (Garg, Salazar-
Ocampo, & van der Donk, 2013). Fractionation of the E. coli cell extract confirmed RNA is key 
to the reaction as well as Glu. Further, Glu-tRNAGlu is identified to participate the activation of 
Ser/Thr side chain through glutamylation and the subsequent elimination of Glu generates the 
double bond (Fig. 2.1 C). However, NisB shows no sequence similarity with other known 
proteins, which hinders further biochemical studies. To gain more insights on the recognition of 
both peptide and tRNA substrates and on the active sites of the glutamylation and elimination 
steps of dehydration reaction, I determined the crystal structure of NisB in the presence of its 
native substrate. Here, I present the 2.9 Å co-crystal structure of NisB in complex with peptide 
substrate NisA, which contains two separate domains for the two steps and NisA binds between 
the domains. The overall structure of NisB is unique but several smaller domains show similarity 
with structures deposited in the Protein Data Bank (PDB), which provide clues on their possible 
roles in the dehydration reaction. A docking model with bacterial tRNAGlu is also established 
based on NisB structure. 
 
Experimental Procedures 
Cloning, Protein Expression and Purification 
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The nisB and nisA genes from nisin gene cluster of Lactococcus lactis sp. lactis were cloned 
and ligated into the MCS I and MCS II of pRSF-Duet vector (Novagen) respectively for co-
expression. The resulting recombinant NisB contained an uncleavable N-termial hexahistitine tag 
(His-tag) while NisA was tagless. This plasmid pRSF-NisB-NisA was transformed into Rosetta 2 
strain for expression. The culture first grew at 37 °C in LB medium supplemented with 50 
µg/mL kanamycin and 25 µg/mL chloramphenicol until O.D.600 reached 0.5. Overexpression of 
NisB and NisA was induced with 0.3 mM IPTG at 18 °C for 20 h. Cells were pelleted by 
centrifugation at 3566 ×g for 25 min (SORVALL RC-3B Plus), resuspended with harvest buffer 
(20 mM Tris pH 8.0, 500 mM NaCl, 10% glycerol) and lysed with French Press (AVESTIN 
EmulsiFlex-C5). The supernatant was collected by centrifugation at 23645 ×g for 1 h (Beckman 
J2-21M/E) and loaded onto a 5mL HisTrap FF colume (GE Healthcare Life Sciences) pre-
equilibrated with wash buffer (20 mM Tris, pH 8.0, 1 M NaCl, 5% glycerol, 30 mM imidazole). 
After washing with the same buffer for 5 column volumes to remove impurities, NisB-NisA 
complex was eluted with elution buffer (20 mM Tris, pH 8.0, 1 M NaCl, 5% glycerol, 200 mM 
imidazole) in a 0-100% linear gradient over 40 mL. Protein purity was checked with SDS-
PAGE. Clean fractions were pooled and subjected to size exclusion chromatography with a 
HiLoad 16/600 Superdex 200 pg column (GE Healthcare Life Sciences) to remove aggregation 
and truncated protein. NisB-NisA complex was concentrated and underwent reductive 
methylation (Walter, et al., 2006). Briefly, 20 µL of 1 M dimethylaminoborane solution (DMAB) 
and 40 µL of 1 M formaldehyde solution were mixed with 1 mL protein solution followed by 
incubation at 4 °C for 2 h. The same solutions were added again and the incubation was repeated. 
After the final addition of 10 µL of 1 M DMAB, the mixture was incubated at 4 °C for 14 h 
before 100 µL of 1 M Tris pH 7.8 was added later to quench the reaction. The centrifuged 
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mixture was subjected to size exclusion chromatography with gel filtration buffer (20 mM 
HEPES pH 7.5, 300 mM KCl). The clean fractions were collected and concentrated for further 
use. The SeMet incorporated NisB-NisA protein was expressed and purified in a similar manner. 
 
Crystallization and Structure Determination 
Sitting drop vapor diffusion method was used for robotic crystallization condition screening 
and two initial hits were obtained (75 mM HEPES pH 7.5, 15% PEG10000, 25% (v/v) glycerol; 
100 mM Bicine pH 8.5, 25% PEG6000). The initial hits were further optimized with hanging 
drop vapor diffusion method and only the second condition gave plate-like crystals suitable for 
diffraction data collection. A typical hanging drop was set up with 1 µL of NisB-NisA complex 
(5 mg/mL) mixed with 1 µL of precipitant solution (100 mM Bicine pH 8.5, 18-24% PEG6000) 
and was equilibrated over a well containing the same solution at 9 °C. Macro-seeding and micro-
seeding facilitated the formation of crystals. SeMet NisB-NisA complex was crystallized in the 
same way. Diffraction-quality crystals were harvested around one week after seeding and 
stepwise equilibrated into crystallization condition supplemented with 10% (v/v) glycerol or 
20% (v/v) ethylene glycol for protection before flash-frozen in liquid nitrogen. 
Native and SeMet NisB-NisA data were collected at Sector 21 ID LS-CAT (Advanced 
Photon Source, Argonne National Labs, Illinois) and integrated and scaled using HKL2000 
(Otwinowski & Minor, 1997) or XDS (Kabsch, 2010). Crystallographic phases were determined 
by single-wavelength anomalous diffraction method (SAD) with the 3.2 Å SeMet NisB-NisA 
data. Heavy atom sites were located using the SHELX suite (Thorn & Sheldrick, 2013), and 
refinement of heavy atom parameters in SHARP (Bricogne, Vonrhein, Flensburg, Schiltz, & 
Paciorek, 2003) yielded an initial figure of merit of 0.276.	  Density modification and two-fold 
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symmetry averaging produced experimental maps that permitted manual assignment of most 
secondary structural elements using COOT (Emsley & Cowtan, 2004). Further model building 
used the 2.9 Å resolution data collected on crystals of native NisB-NisA. Although obvious 
electron density corresponding to the NisA peptide	   can be observed in experimentally phased 
maps, the peptide was only built into the model once the free R factor for the structure had 
decreased to below 0.30. The validity of all models was routinely determined with 
MOLPROBITY (Chen, et al., 2010) and by using the free R factor to monitor improvements 
during building and crystallographic refinement. 
 
Results 
Overall structure of NisB-NisA complex 
In order to investigate the structural basis of the dehydration reaction and substrate 
recognition, we determined the 2.9 Å crystal structure of NisB in complex with its peptide 
substrate NisA. The 117-kDa NisB forms a dimer in the asymmetric unit (Fig. 2.2 A), consistent 
with the previous report in which the experimentally predicted NisB molecular weight in 
aqueous solution corresponds to a dimeric composition. The two protomers in the asymmetric 
unit clutch each other and face the opposite directions. In each protomer, residues S5–I706 
constitute the N-terminal large domain and residues R716–E990 compose the C-terminal small 
domain (Fig. 2.2 A). The two domains form a cleft and NisA peptide binds in the cleft (Fig. 2.2 
B). Residues spanning I706–R716 and V893–G919 were not modeled in the structure due to the 
lack of electron density. 
Mutations in NisB that have been demonstrated to interfere with either glutamate addition 
(glutamylation reaction) or elimination reactions cluster separately into the N-terminal domain or 
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C-terminal domain in the structure (Fig. 2.3 A). Mutations that abolished the glutamylation 
reaction but retained in vitro glutamate elimination activity on glutamylated NisA intermediates 
(Garg, Salazar-Ocampo, & van der Donk, 2013) locate within a 10 Å-radius region in the N-
terminal domain (Fig. 2.3 B). This domain is therefore designated glutamylation domain. 
Likewise, mutations of R786, R826 and H961 that led to accumulation of glutamylated peptide 
intermediates and thus were important for elimination activity (Garg, Salazar-Ocampo, & van 
der Donk, 2013) cluster in a small region in the C-terminal domain (Fig. 2.3 C), together with 
other residues crucial for NisB dehydration process (Garg, Salazar-Ocampo, & van der Donk, 
2013). This domain is consequently designated elimination domain. The regions harboring the 
catalytically crucial residues are proposed to be the glutamylation site and elimination site, 
respectively. Interestingly, the partitioned two domains correspond to two discrete proteins of 
around 800 residues and 300 residues encoded in thiopeptide biosynthetic gene clusters (Li & 
Kelly, 2010), which indicates that the dehydration of thiopeptide is achieved in a similar manner 
– aminoacylation and elimination catalyzed by these two proteins. 
 
tRNA Binding Cavity of NisB 
RNA-binding proteins often contain positively charged patches on the accessible surface to 
mediate electrostatic interactions with their polyanionic cognate RNAs (Shazman & Mandel-
Gutfreund, 2008). The surface electrostatic potential calculation on NisB reveals a densely 
positively charged cavity on the inner surface of the glutamylation domain (Fig. 2.4 A). The 
dimensions of this cavity could suitably accommodate the characteristic L shape of a typical 
tRNA. Based on the limited structural similarity of this region to the Xenopus laevis double-
stranded RNA-binding protein A complexed with its cognate RNA (PDB 1DI2), a docking 
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model was proposed for NisB binding to a bacterial tRNAGlu, using the structure of tRNAGlu 
from Thermus thermophilus (PDB 1N78) (Fig. 2.4 B). The binding of tRNA to the positively 
charged cavity in NisB is mainly through the acceptor stem, which is for amino acid attachment. 
This suggests glutamylation domain possibly recognizes the acceptor stem instead of the overall 
L shape of tRNA. Similar interactions have been observed in peptidyltransferases that utilize 
aminoacyl tRNA for nonribosomal peptide synthesis, such as the peptidyltransferase FemX 
involved in the synthesis of the pentapeptide in peptidoglycan precursor (Mainardi, Villet, Bugg, 
Mayer, & Arthur, 2008). FemX contains a positively charged grove that reaches to the catalytic 
site (Biarrotte-Sorin, Maillard, Delettré, Sougakoff, Arthur, & Mayer, 2004) and its activity 
depends on correct recognition of the acceptor stem of the tRNA donor, demonstrated by both 
biochemical and structural studies (Fonvielle, et al., 2009; Fonvielle, et al., 2013). Although 
NisB catalyzes entirely different reaction from FemX and has a much more complicated 
structure, it could use a similar strategy to bind the tRNA substrate. Moreover, the docking 
model also shows the tRNA acceptor stem is placed in proximity to the glutamylation site, as a 
further support for the model. 
 
Structural Homology of NisB 
Structural similarity search of NisB against Protein Data Bank (PDB) gave no obviously 
homologous structure, but searching with smaller domains gave several structurally similar 
domains or proteins. The domain spanning residues F136–I216 in glutamylation domain 
resembles the N-terminal domain of LynD (and TruD) (Fig. 2.5 A), the heterocyclase involved in 
cyanobactins biosynthesis (Koehnke J. , et al., 2013; Koehnke, et al., 2015). It contains a three-
stranded antiparallel β sheet followed by a three-α helical bundle and is named winged helix-
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turn-helix motif (wHTH). wHTH typically recognizes DNA with its alpha helix in the binding 
event of transcription factors (Brennan, 1993). In the case of NisB or LynD, this domain 
recognizes the conserved N-terminal leader peptide or recognition sequence (RS) of the peptide 
substrate. Residues from both α helical bundle and a β strand provide interactions with the 
peptide. Leader peptide or RS binds the helical bundle of wHTH with its N-terminus and 
stretches out as a β strand to join the antiparallel β sheet. Although catalyzing distinct chemical 
reactions in the biosynthesis of different RiPP classes, NisB and LynD do share a common 
feature as RiPP processing enzymes – the scheme for peptide binding, suggesting a more 
universal role of this domain in enzyme-peptide substrate interaction. 
A α/β subdomain spanning F734–Y820 in the elimination domain of NisB is structurally 
homologous to the protein LsrG in bacterial interspecies quorum sensing system (Fig. 2.5 A). 
LsrG catalyzes epimerization of processed autoinducer-2 molecule by abstracting a proton 
adjacent to a carbonyl group (Marques, et al., 2011). Despite their similar structure that consists 
a four-stranded β sheet flanked by α helices, the active site of LsrG is not conserved in NisB 
elimination domain. The proposed active site residues of LsrG are placed between the β sheet 
and α helices based on the observation of electron density of an unidentified ligand in the 
structure (Fig. 2.5 B). However, the residues crucial for NisB glutamate elimination are located 
between the LsrG-like subdomain and the second subdomain of the elimination domain (Fig. 2.5 
C). Scrutinization of this region led to the identification of an additional conserved basic residue 
in the pocket, R784. Alanine substitution of R784 resulted in the accumulation of glutamylated 
peptide intermediates as predicted, further supporting the assignment of the active site for the 
elimination reaction. 
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Peptide Binding Site of NisB 
Although NisB is co-purified with the full-length NisA, only continuous electron density of 
residues K-20 to K-9 of NisA leader peptide was clearly observed in the peptide-binding groove 
between the glutamylation domain and the elimination domain (Fig. 2.6). The electron density 
diminishes towards the C-terminus of the leader peptide and the entire core peptide, possibly due 
to their flexible conformation and transient interaction with NisB. The NisA leader peptide forms 
a β strand and interacts antiparallely with the β strand of the peptide-binding domain, spanning 
residues L166–N175 (Fig. 2.2 A). The location of the leader-binding groove and the extended 
conformation of the leader peptide ensure that the core peptide, instead of any residue in the 
leader region, can flexibly reach both the distant glutamylation site and elimination site. 
Conserved in other class I lantibiotics, NisA contains a F-D/N-L-N/D motif essential for NisB 
recognition (Mavaro, et al., 2011; Plat, Kluskens, Kuipers, Rink, & Moll, 2011; Khusainov, 
Moll, & Kuipers, 2013). The F-18 of the motif is situated in a hydrophobic cage formed by NisB 
residues V176, V198, Y202, L209 and Y213 (Fig. 2.6). The L-16 interacts with NisB 
hydrophobically in a pocket composed of I171, Y213 and L217 (Fig. 2.6). The D-15 of the 
conserved motif forms hydrogen bond with R154 of NisB (Fig. 2.6). The extensive interactions 
between NisA FNLD motif and NisB in the crystal structure support and explain the observation 
that mutations in this motif greatly decrease the binding affinity of NisA to NisB. 
 
Discussion 
As one of the longest known lantibiotic, nisin has been under intensive investigation for 
decades, with respect to its in vivo production, regulation, mode of action, and industrial 
application. However, the detailed biosynthetic process wasn’t elucidated until recently, 
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especially the synthesis of dehydrated amino acids. NisB was assigned as the dehydratase based 
on in vivo experiments, but it was the successful in vitro reconstitution of NisB activity and the 
decoupling of glutamylation and glutamate elimination reactions that significantly advance the 
understanding and promote the further illustration of the tRNA dependent mechanism. Here, we 
reported the 2.9 Å crystal structure of NisB-NisA complex, the first structure of class I lantibiotic 
dehydratase. The glutamylation and elimination reactions are isolated from each other spatially 
in two separate active sites in glutamylation domain and elimination domain, respectively. The 
peptide substrate is positioned in the peptide-binding groove between the two domains, allowing 
for reaching either of the active site and proper movement between the two sites. The flexibility 
of NisA core peptide could explain the diminished electron density for the NisA C-terminus in 
the structure. In contrast, the leader peptide is tightly held by the leader peptide-binding domain 
of NisB, mainly through hydrophobic interactions with the NisA FNLD motif. The retainment of 
this highly conserved motif in class I lantibiotic precursor peptides suggests their cognate 
dehydratases use a similar mechanism for peptide recognition. That the NisB leader peptide-
binding domain is isolated from catalytic sites provides explanations for the observation that 
Ser/Thr residues in the leader peptide are never dehydrated and that a minimal distance is 
required between the FNLD motif and the first dehydrated amino acid (Plat, Kluskens, Kuipers, 
Rink, & Moll, 2011). The leader peptide is protected by the leader-binding domain in the 
structure and the minimal distance required is the distance between this motif and the 
glutamylation site. This distance also justifies the general N-to-C directionality and distributive 
manner of NisA dehydration reactions catalyzed by NisB: residues closer to the leader peptide 
are more likely to access the glutamylation site than the C-terminal residues. 
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As the representative LanB protein, the structure of NisB in complex with NisA shed lights 
on the catalytic mechanism and substrate recognition of other LanBs in the biosynthesis of 
respective class I lantibiotics. Based on sequence similarity of class I LanBs, the cognate Glu-
tRNAGlu dependent two-step dehydration mechanism is likely a prevalent strategy. The discrete 
glutamylation site, elimination site and the leader peptide-binding motif are possibly also 
conserved. Further study on the mechanism and structure of other LanBs will be necessary to 
confirm this prediction. Besides, LanB gene homologs are also widely identified in the 
biosynthetic gene clusters of other RiPP classes, such as in the aforementioned thiopeptide gene 
clusters. The glutamylation and elimination domains of NisB are encoded as two separate 
polypeptides but the two-step reaction strategy probably also applies here to achieve dehydrated 
amino acids. Whether these enzymes prefer Glu-tRNAGlu or other amino acids, however, is 
worth investigating. 
Aminoacyl-tRNA has been shown to participate diverse chemical transformations and 
cellular processes apart from the canonical ribosomal polypeptide synthesis (Francklyn & 
Minajigi, 2010). In the biosynthesis of amino-acid-containing natural products, it often serves as 
the donor of activated amino acid and peptide bond or isopeptide bond is formed to attach the 
amino acid as part of the final product. In contrast, the NisB dehydration reaction utilizes the 
activated amino acid as the replacement of ATP to activate another amino acid and bring in a 
“good” leaving group. An ester bond rather than peptide bond is formed to ensure the subsequent 
elimination together with proton abstraction. This novel usage of aminoacyl-tRNA for amino 
acid activation is an addition to its diverse functions other than ribosomal polypeptide synthesis. 
Nevertheless, although a tRNA-binding site is observed on NisB and a binding model is 
proposed, structures of the NisB-NisA-GlutRNAGlu or NisB-NisA-acceptor stem trimeric 
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complex will be desired to thoroughly evaluate the NisB conformational changes in different 
stages of the catalytic cycle, and to illustrate the interactions between the acceptor stem and the 
tRNA-binding site, between the aminoacylated 3’ end and the glutamylation active site, and 
between the glutamyl group and the Ser/Thr of NisA core peptide. 
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Figures 
 
 
 
Fig. 2.1    A. Nisin biosynthetic gene cluster from Lactococcus lactis. nisA encodes the precurspr 
peptide; nisB and nisC encode the dehydratase and cyclase, respectively; nisT encodes the 
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transporter for nisin secretion and nisP encodes the extracellular protease; nisRK encode the two-
component regulatory system; nisI and nisFEG are immunity genes. B. The biosynthetic 
pathway of nisin. Ribosomally synthesized NisA precursor peptide contains leader peptide and 
core peptide. The latter undergoes post-translational modifications catalyzed by dehydratase 
NisB and cyclase NisC. Ser (green) is converted to Dha and Thr (purple) is converted to Dhb by 
NisB. NisC catalyzes the nucleophilic attack of Cys side chain onto the Dha and Dhb to form 
Lan (red) and MeLan (blue). The subsequent leader peptide removal generates the mature nisin. 
C. Mechanism of dehydration reaction. NisB uses Glu carried on Glu-tRNAGlu to activate Ser 
and Thr. The side chain hydroxyl group attacks the ester bond of Glu-tRNAGlu and gets 
glutamylated. The subsequent elimination of Glu by NisB produces dehydrated amino acid. 
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Fig. 2.2    A. Overall structure of NisB in complex with peptide substrate NisA. NisB forms a 
dimer in the crystal structure. One protomer is in gray; the other protomer is colored differently 
with two domains. The N-terminal large domain is in purple and the C-terminal small domain is 
in green. NisA peptide is colored in gold. B. Surface representation of NisB dimer. NisA peptide 
is shown as spheres with oxygen atoms colored in red and nitrogen atoms colored in blue. 
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Fig. 2.3    A. A protomer of NisB with corresponding NisA substrate. The N-terminal 
glutamylation domain is colored in purple and the C-terminal elimination domain is colored in 
green. NisA peptide is shown as a β strand in gold. The residues essential for either 
glutamylation reaction or elimination reaction are clustered separately and shown as sticks. B. A 
close view of residues important for Ser/Thr glutamylation reaction. C. A close view of residues 
important for glutamate elimination reaction. 
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Fig. 2.4    A. Surface representation of a NisB protomer showing surface electrostatics. Blue 
colored region represents positively charged surface; red colored region represents negatively 
charged surface. The saturation of the color is positively correlated with the density of the 
charge. Electroneutral surface is colored white. The highly basic region in glutamylation domain 
is proposed as the tRNA-binding site. NisA peptide is shown as a β strand in gold. B. A docking 
model of bacterial tRNAGlu onto NisB. The NisB glutamylation domain is colored purple and the 
elimination domain is in green. The tRNA is shown as spheres and NisA peptide is shown as 
sticks. The acceptor stem of tRNA is bound at the proposed tRNA-binding site and points to the 
region with residues important for glutamylation reaction. 
  
tRNA	  site 
tRNA 
A B 
	   45	  
 
 
Fig. 2.5    A. Structure homology of NisB. Homology search with a NisB protomer or either of 
the two domains showed no similar structure in PDB. Smaller domains in NisB are structurally 
similar to known proteins. The leader-binding domain of NisB is homologous to the LynD N-
terminal domain, which is also responsible for binding the recognition sequence of the peptide 
substrate. A small domain in the elimination domain is homologous to LsrG involved in 
degradation of quorum-sensing molecule. B. Structure of LsrG with the proposed active-site 
residues shown in sticks. Based on the electron density of an unidentified substrate in the LsrG 
LsrG 
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crystal structure, the active site is proposed to be between the β sheet and α helices. C. The 
elimination domain of NisB. It is divided into two domains and the α/β domain homologous to 
LsrG is colored in yellow. Compared to the proposed LsrG active site, the active site for NisB 
elimination reaction is located between the two domains and composed of residues from both 
domains (shown as sticks). 
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Fig. 2.6    NisA leader peptide coordination in NisB leader-binding site. The residues K-20 
through K-9 (shown as sticks in orange) observed in the co-crystal structure are coordinated 
through hydrophobic interactions and hydrogen bonds. NisB residues I171, V176, V198, Y202, 
L209 and Y213 form a hydrophobic cage to accommodate the F-18 and L-16 in the conserved 
FNLD motif in the leader peptide. NisB residue R154 interacts with D-15 through hydrogen 
bond. The leader peptide forms a β strand antiparallel to the β strand in the leader-binding site 
and hydrogen bonds through backbone atoms also assist in substrate coordination. 
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2.2 Structural Study of Lantibiotic Dehydratase MibB in Microbisporicin Biosynthesis 
 
Introduction 
Infections caused by Gram-positive pathogens represent a global challenge and multidrug-
resistant strains keep emerging. An effective strategy in treating Gram-positive bacteria is to 
disrupt cell wall biosynthesis. Lantibiotics are promising chemotherapeutic agents in inhibiting 
peptidoglycan synthesis, especially for the resistant strains, and they show no cross-resistance 
with glycopeptides (Cotter, Hill, & Ross, 2005). Microbisporicin is a class I lantibiotic 
discovered recently through high-throughput screening of uncommon actinomycete broth 
extracts for peptidoglycan biosynthesis inhibitors except β-lactams and glycopeptides. With the 
commercial name NAI-107, it is in late preclinical-phase trials and demonstrated potent 
inhibitory activity against a panel of Gram-positive pathogenic bacteria, including methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE), with 
comparable or superior efficacy with respect to other antibiotics tested such as lantibiotic nisin 
and vancomycin (Castiglione, et al., 2008; Jabés, Brunati, Candiani, Riva, Romanó, & Donadio, 
2011). And it is more active in treating Gram-negative bacteria Moraxella catarrhalis, Neisseria 
spp. and Haemophilus influenzae. Similar to the well studied class I lantibiotic nisin, it binds cell 
wall precursors such as lipid I and lipid II and preferentially forms a 2:1 complex. It disrupts cell 
membrane and depolarizes it, but unable to form pores on the membrane to cause acute cessation 
of DNA, RNA and protein biosynthesis (Münch, et al., 2014). 
Microbisporicin contains 3 lanthionine (Lan), 1 methyllanthionine (MeLan) crosslinks and a 
C-terminal S-((Z)-2-aminovinyl)-D-cysteine (AviCys), which prevents C-terminal hydrolysis. It 
also has two unusual modifications: 5-chlorotryptophan and 3,4-dihydroxylproline, which are 
	   49	  
unique among lantibiotics (Fig. 2.7 B). There is not much known about microbisporicin 
biosynthesis, but the general biosynthetic route can be predicted from its gene cluster (Fig. 2.7 
B). The cluster was identified and annotated in Microbispora corallina lately and was shown to 
successfully produce active microbisporicin heterologously (Fig. 2.7 A). It encodes precursor 
peptide MibA, maturation enzymes for installing all functional groups and for secretion, 
immunity proteins and transcription regulators for feed-forward regulation (Foulston & Bibb, 
2010; Foulston & Bibb, 2011). MibA is a 57-residue precursor peptide with the first 33 amino 
acids as leader peptide. The leader contains the conserved “FNLD” recognition motif (LDLD in 
MibA) and a typical leader cleavage site. Same as other class I lantibiotics, MibB and MibC are 
encoded separately and show sequence similarities with representative LanB and LanC proteins, 
respectively (Foulston & Bibb, 2010). 
The LanB protein in nisin biosynthesis, NisB, has recently been characterized as a tRNA-
dependent dehydratase and catalyzes both glutamylation and elimination steps. Apart from its 
cognate Glu-tRNAGlu, NisB is capable of using E. coli Glu-tRNAGlu for the reaction with both in 
vitro and in vivo evidence (Garg, Salazar-Ocampo, & van der Donk, 2013; Ortega, Hao, Zhang, 
Walker, & van der Donk, 2015). It is intriguing to evaluate the prevalence of this biosynthetic 
scheme in class I lantibiotic biosynthesis, as well as in other biosynthetic pathways involving 
LanB homologs. MibB, encoded by a rare actinomycete, serves as a suitable candidate to address 
questions such as whether utilization of tRNA is a common strategy for LanBs, whether a 
specific variant of Glu-tRNA is preferred and whether E. coli Glu-tRNA could be recognized 
and function universally. As part of the assessment, I determined the MibB structure at 2.7 Å 
without peptide substrate. MibB appears as a dimer in the crystal structure and is composed of 
two domains similar to those in the previously determined NisB structure. The residues crucial 
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for glutamylation reaction and elimination reaction in NisB are also conserved in MibB structure 
and mapped separately in the two domains. Close to MibB putative glutamylation site, there is a 
highly basic region potentially for tRNA recognition. MibB also contains a α+β domain for 
leader peptide binding as in NisB. However due to the poor solubility of peptide substrate, 
attempt on co-crystalling MibB-MibA complex was not successful. 
 
Experimental Procedures 
Cloning, Protein Expression and Purification 
The mibB gene from microbisporicin gene cluster of Microbisppora corallina was cloned 
into pET-28b vector (Novagen) between NdeI and XhoI sites. The resulting plasmid was 
transformed into Rosetta 2 strain for expression. The culture first grew at 37 °C in LB medium 
supplemented with 50 µg/mL kanamycin and 25 µg/mL chloramphenicol until O.D.600 reached 
0.5. Overexpression of MibB was induced with 0.3 mM IPTG at 18 °C for 20 h. Cells were 
pelleted by centrifugation at 3566 ×g for 25 min (SORVALL RC-3B Plus), resuspended with 
harvest buffer (20 mM Tris pH 8.0, 500 mM NaCl, 10% glycerol) and lysed with French Press 
(AVESTIN EmulsiFlex-C5). The supernatant was collected by centrifugation at 23645 ×g for 1 
h (Beckman J2-21M/E) and loaded onto a 5 mL HisTrap FF colume (GE Healthcare Life 
Sciences) pre-equilibrated with wash buffer (20 mM Tris, pH 8.0, 1 M NaCl, 5% glycerol, 30 
mM imidazole). After washing with the same buffer for 5 column volumes to remove impurities, 
MibB was eluted with elution buffer (20 mM Tris, pH 8.0, 1 M NaCl, 5% glycerol, 200 mM 
imidazole) in a 0-100% linear gradient over 40 mL. Protein purity was checked with SDS-
PAGE. Clean fractions were pooled and subjected to size exclusion chromatography with a 
HiLoad 16/600 Superdex 200 pg column (GE Healthcare Life Sciences) to remove aggregation 
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and truncated protein. MibB was concentrated and underwent reductive methylation (Walter, et 
al., 2006). Briefly, 20 µL of 1 M dimethylaminoborane solution (DMAB) and 40 µL of 1 M 
formaldehyde solution were mixed with 1 mL protein solution followed by incubation at 4 °C for 
2 h. The same solutions were added again and the incubation was repeated. After the final 
addition of 10 µL of 1 M DMAB, the mixture was incubated at 4 °C for 14 h before 100 µL of 1 
M Tris pH 7.8 was added to quench the reaction. The centrifuged mixture was subjected to size 
exclusion chromatography with gel filtration buffer (20 mM HEPES pH 7.5, 300 mM KCl). 
Clean fractions were collected and concentrated for further use. 
 
Crystallization and Structure Determination 
A sitting drop vapor diffusion method was used for robotic crystallization condition 
screening. The initial hit (100 mM HEPES pH 7.5, 20% (v/v) ethanol) was further optimized 
with hanging drop vapor diffusion method. A typical hanging drop was set up with 2 µL of MibB 
(7 mg/mL) mixed with 2 µL of precipitant solution (100 mM HEPES pH 7.5 or 100 mM MOPS 
pH 7.9, 16-22% (v/v) ethanol) and was equilibrated over a well containing the same solution at 
16 °C. Rod-like diffraction-quality crystals were harvested around one week after setting up and 
stepwise equilibrated into crystallization condition supplemented with 20% (v/v) ethylene glycol 
for protection before flash-frozen in liquid nitrogen. 
Crystallographic phases were determined by multiple isomorphous replacement method 
(MIR) using heavy atom derivative with potassium hexachloroosmate (IV). Native and 
derivative MibB data were collected at Sector 21 ID LS-CAT (Advanced Photon Source, 
Argonne National Labs, Illinois) and integrated and scaled using HKL2000 (Otwinowski & 
Minor, 1997) or XDS (Kabsch, 2010). Heavy atom sites were located using the SHELX suite 
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(Thorn & Sheldrick, 2013), and refinement of heavy atom parameters in SHARP (Bricogne, 
Vonrhein, Flensburg, Schiltz, & Paciorek, 2003) yielded an initial figure of merit of 0.274.	  
Density modification and two-fold symmetry averaging produced experimental maps that 
permitted manual assignment of most secondary structural elements using COOT (Emsley & 
Cowtan, 2004). A higher-resolution data set was collected at Station F at CHESS (Cornell 
University, New York) and integrated and scaled using XDS. Refinement of the initial model 
against this data set allowed for a near complete model to be manually built. The validity of all 
models was routinely determined with MOLPROBITY (Chen, et al., 2010) and by using the free 
R factor to monitor improvements during building and crystallographic refinement. 
 
Results 
In order to gain structure insights of the putative dehydratease MibB and the dehydration 
reaction it catalyzes, we determined the 2.7 Å crystal structure of MibB. MibB crystallize as a 
dimer in the asymmetric unit with two protomers clutching each other and facing the opposite 
directions (Fig. 2.8). The 120-kDa protomer is divided into a large N-terminal domain and a 
small C-terminal domain, forming a cleft between the two domains. Residues D4–S809 compose 
the N-terminal domain and residues P819–H1114 comprise the C-terminal domain. Residues 
E20 through D78 were not modeled into the structure due to the lack of electron density. 
The overall structure of MibB is homologous to the recently characterized structure of class I 
lantibiotic dehydratase NisB although they share only 20% sequence identity. The two dimeric 
structures superimpose decently with a RMSD of 3.5 Å (Fig. 2.9). Since NisB exists as a dimer 
in the aqueous solution and crystalizes as a dimer, the structurally homologous MibB may also 
function as a dimer, which suggests the possibility that the homodimer formation is essential for 
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the reaction catalyzed by class I LanB enzymes. MibB also shares notable structural features of 
NisB that are essential and characteristic for a tRNA-dependent lantibiotic dehydratase and 
indicate a similar two-step dehydration mechanism. 
Primary sequence alignment of MibB and NisB reveals that the residues essential for NisB 
glutamylation and elimination reactions are all conserved in MibB. Similar to NisB, the two 
groups of residues cluster in the N-terminal domain and C-terminal domain respectively (Fig. 
2.10). Corresponding MibB residues that are important for glutamylation reaction in NisB locate 
within a 10 Å-radius region in MibB N-terminal domain. This domain is therefore designated 
glutamylation domain (Fig. 2.11 A, B). Likewise, corresponding MibB residues that are 
important for glutamate elimination reaction in NisB cluster in a small region in the C-terminal 
domain. This domain is thus designated glutamate elimination domain (Fig. 2.11 A, C). The 
regions harboring the conserved catalytically crucial residues are proposed to be the 
glutamylation site and elimination site as in the case of NisB. 
Similar to NisB, the region close to the glutamylation site is structurally homologous to the 
Xenopus laevis double-stranded RNA-binding protein A (PDB 1DI2) and is highly positively 
charged on the surface (Fig. 2.11 D). The dimensions of this region are close to the ones of the 
proposed tRNA-binding pocket on NisB, and thus it might as well be responsible for aminoacyl-
tRNA substrate recognition by interacting with the acceptor stem. A small domain spanning 
residues Q201–L286 in MibB glutamylation domain resembles the leader peptide-binding 
domain identified in NisB (Fig. 2.11 E, F). Although the MibB structure presented here is not in 
complex with its peptide substrate MibA, this domain is predicted to contribute to MibA leader 
peptide binding from structure homology. With the presence of the conserved LDLD motif in 
MibA leader peptide, similar hydrophobic and hydrogen-bonding patterns between this motif and 
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the MibB leader peptide-binding domain are expected based on the observed interactions in 
NisB-NisA complex structure (Fig. 2.12 A, B). Compared to the NisB leader-binding domain 
bound with NisA leader, the MibB leader-binding domain demonstrates an obvious 
conformational change (Fig. 2.12 C). The α helical bundle is shifted outwards with respect to the 
β sheet, suggesting less engagement of the residues comprising the hydrophobic cage in a leader-
free state. Notably, the utilization of homologous leader peptide-binding domain for substrate 
recognition is observed beyond the class I lanthipeptides. The heterocyclases LynD and TruD in 
the biosynthesis of cyanobactins, another class of RiPPs, contain a similar fold at the N-terminus 
and have been shown structurally to recognize the corresponding recognition sequence in peptide 
substrate. Despite the drastically different protein structures and reactions they catalyze, the 
lantibiotic dehydratases and cyanobactin heterocyclases do depend on leader peptide (or 
recognition sequence) recognition for catalysis, suggesting a general role of this scaffold in 
proper peptide binding in RiPP biosynthesis. 
 
Discussion 
Recent biochemical and structural studies on lantibiotic dehydratase NisB revealed that the 
dehydrated amino acids of class I lantibiotics are installed by NisB in a Glu-tRNAGlu dependent 
manner and through glutamylation and glutamate elimination steps. To evaluate the universality 
of this dehydration mechanism in class I lantibiotic biosynthesis, we provided the structural 
support by determining the 2.7 Å crystal structure of MibB, the putative dehydratase involved in 
the biosynthesis of the newly discovered class I lantibiotic microbisporicin produced by an 
uncommon actinomycete. MibB shows high structural homology with NisB, including the key 
features that support a tRNA-dependent two-step dehydration mechanism. As with NisB, MibB 
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consists of the N-terminal glutamylation domain and C-terminal glutamate elimination domain 
with the conserved catalytically important residues grouping in a small region of the respective 
domains. Primary sequence alignment of MibB, NisB, with SpaB involved in subtilin 
biosynthesis reveals that these important residues are highly conserved in lantibiotic 
dehydratases (Fig. 2.10), indicating that the two-step strategy of introducing dehydrated amino 
acids is probably universal in class I lantibiotic biosynthesis. A similar RNA-binding fold with 
positively charged surface is identified near the MibB glutamylation site and proposed to 
recognize the Glu-tRNAGlu based on the comparison with NisB. However, while NisB doesn’t 
distinguish between the E. coli Glu-tRNAGlu and its cognate Glu-tRNAGlu as glutamate donor, 
MibB strictly depends on its cognate Glu-tRNAGlu for activity. Despite the expected electrostatic 
interactions between NisB/MibB and the tRNA acceptor stem, additional recognition 
mechanisms are believed to participate in determining the tRNA selectivity, such as the 
interactions between specific residues in the tRNA-binding pocket and the bases of the acceptor 
stem at specific positions. To answer this question, a structure of NisB/MibB in complex with 
the cognate Glu-tRNAGlu or with acceptor stem analogs will be desired to thoroughly elucidate 
the recognition mechanism. 
Despite the lack of substrate MibA peptide in the MibB structure, a small domain 
homologous to the leader peptide-binding domain of NisB is observed at the boundary of the 
MibB glutamylation domain and elimination domain. Predicted from the leader peptide 
recognition pattern in NisB, this domain is the leader peptide-binding domain of MibB and 
recognizes MibA leader peptide in a similar manner. In addition, the location of this domain 
would preferentially allow the movement of MibA core peptide between the glutamylation and 
elimination active sites. As mentioned above, the same structural fold also serves as the 
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recognition sequence-binding domain of the heterocyclase involved in cyanobactin biosynthesis. 
A recent study demonstrated that this domain is actually widely distributed in the leader peptide-
dependent biosynthetic enzymes of diverse RiPP classes (Burkhart, Hudson, Dunbar, & Mitchell, 
2015), indicating a general strategy for peptide substrate recognition. However, it remains 
elusive but is intriguing to investigate how prevalent this strategy is among different RiPP 
modifying enzymes and whether additional structural scaffolds are also used for leader peptide 
recognition. 
An apparent difference between the MibB leader-binding domain and that of NisB is the 
movement of the α helical bundle with respect to the β sheet. This conformational change could 
be explained by several possibilities. It might represent the intrinsic arrangement of structural 
elements in MibB that is distinct from NisB, even though they utilize similar strategy for leader 
peptide recognition. A second possible explanation for the conformational change is that it might 
result from the absence of substrate peptide, which signals the peptide-binding domain to stay in 
a less engaged state. The binding of substrate peptide could possibly introduce a conformational 
change and the α helical bundle therefore moves closer to the β sheet to clutch the peptide 
substrate. To interpret this observation properly, structure of MibB in complex with its cognate 
substrate MibA is desired for comparison. 
An interesting phenomenon is the similar dimeric structure of NisB and MibB, two class I 
LanB enzymes from distinct bacterial phyla. First, this similarity indicates that the dimeric 
structure is likely to be universal for class I lantibiotic dehydratases despite the drastic 
differences of the source organism. Second, the dimer formation is possibly a prerequisite for 
proper catalysis by LanB enzymes. It is obvious in both MibB and NisB structures that the 
distance for a peptide substrate to reach the elimination site of the same protomer is much longer 
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than that to the corresponding elimination site of the other protomer. It could be explained by a 
possible trans manner of the glutamate elimination step.  The NisA peptide is glutamylated in the 
protomer it is located in but might take a shorter path and gets eliminated in the elimination site 
of the other protomer. To further investigate this possibility, a co-crystal structure of LanB with 
its cognate LanA locked in the elimination site would be necessary. 
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Figures 
 
 
 
Fig. 2.7    A. Microbisporicin biosynthetic gene cluster from Microbispora corallina. mibA 
encodes precursor peptide; mibB and mibC encode lantibiotic dehydratase and cyclase, 
respectively; mibD encodes a putative flavoprotein to decarboxylate the C-terminus and catalyze 
AviCys formation; mibHS encode a putative flavin-dependent halogenase for Trp chlorination; 
mibO encodes a putative P450 for Pro hydroxylation; mibTU, ABC transporters; mibEF, 
immunity genes; the product of mibX, mibW, mibR are involved in transcriptional regulation. B. 
Biosynthetic pathway of microbisporicin A1.  
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Fig. 2.8    A. Overall structure of MibB. MibB forms a dimer in the crystal structure. One 
protomer is in gray; the other protomer is colored differently with two domains. The N-terminal 
large domain is in purple and the C-terminal small domain is in green. B. Surface representation 
of MibB dimer. 
  
A 
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Fig. 2.9    A. Superimposition of MibB dimer with NisB dimer. MibB is colored in gold and 
NisB is colored in cyan. B. Superimposition of MibB protomer with NisB protomer. There are 
no substantial structural differences between the two class I lantibiotic dehydratases from 
different phyla of bacteria. 
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Fig. 2.10    Sequence alignment of three class I lantibiotic dehydratases MibB, NisB and SpaB. 
Residues important for glutamylation reaction and elimination reaction are highly conserved and 
indicated with purple and green arrowheads, respectively. 
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Fig. 2.11    A. A protomer of MibB with glutamylation domain (purple) and elimination domain 
(green). The residues essential for either glutamylation reaction or elimination reaction are 
clustered separately into the two domains and shown as sticks (cyan). B. A close view of 
Glutamylation	  domain 
Elimination	  domain 
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  binding	  domain 
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conserved residues important for Ser/Thr glutamylation reaction. C. A close view of conserved 
residues important for glutamate elimination reaction. D. Surface representation of MibB 
protomer showing surface electrostatics. Blue colored region represents positively charged 
surface; red colored region represents negatively charged region. The saturation of the color is 
positively correlated with the density of the charge. Electroneutral surface is colored white. The 
highly basic region in glutamylation domain is proposed as the tRNA-binding site. E. The NisB 
leader-binding domain spanning residues A147–H221. F. The MibB domain spanning residues 
L202–E279 is proposed as the leader peptide-binding domain, based on structural homology 
with the NisB leader-binding domain. 
  
	   64	  
 
 
Fig. 2.12    A. NisB leader-binding domain (cyan) bound with NisA leader peptide (pink). 
Residues involved in hydrophobic interactions and hydrogen-bonding interactions with the 
conserved NisA FNLD motif are shown as sticks. B. Proposed MibB leader-binding domain 
(gold). MibA contains a LDLD motif in the leader peptide. Despite the lack of MibA in the 
crystal structure, residues potentially important for LDLD motif recognition are identified based 
A 
B 
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on the structural homology with NisB leader-binding domain. C. Superimposition of MibB 
leader-binding domain (gold) and NisB leader-binding domain (cyan). An outward shift of the α 
helices is observed with respect to the β sheet in MibB leader-binding domain compared with the 
NisB leader-binding domain. 
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Chapter 3    Structural and Biochemical Studies on the N-Methyltransferases 
 in Plantazolicin Biosynthesis1 
 
Introduction 
Plantazolicin (PZN) was first isolated from the Gram-positive plant growth-promoting 
rhizobacterium Bacillus amyloliquefaciens FZB42 and selectively inhibits the growth of closely 
related Bacilli, including the anthrax-causing bacterium Bacillus anthracis (Scholz, et al., 2011; 
Molohon, et al., 2011). PZN is a linear azol(in)e-containting peptide (LAP). The 41-residue 
precursor peptide is synthesized on the ribosome and contains a 27-residue long leader peptide 
and a Cys/Ser/Thr rich core peptide (Fig. 3.1 B). The Cys/Ser/Thr residues are clustered into two 
adjacent patches and converted to two poly-azol(in)e moieties by the BCD tailoring enzyme 
complex (Kalyon, et al., 2011; Molohon, et al., 2011). The heterocyclase D catalyzes ATP-
dependent cyclodehydration reaction and azoline rings form between the side chain of 
Cys/Ser/Thr and the preceding amide bond. The dehydrogenase B then oxidizes the azolines to 
corresponding aromatic azoles. A total of 10 azolines are installed with 5 in each patch and the 
first 9 of them are oxidized, leaving the last methyloxazoline ring susceptible to hydrolysis. The 
leader peptide is cleaved by a zinc dependent protease, yielding the rigid desmethylPZN. The last 
post-translational modification that confers the bioactivity is the leader-independent 
dimethylation of the N-terminal Arg (Fig. 3.1 B). The desmethylPZN with unmodified N-
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Part of this chapter is adapted from the following published articles: 
 
Lee, J., Hao, Y., Blair, P. M., Melby, J. O., Agarwal, V., Burkhart, B. J., Nair, S. K., & Mitchell, D. A. (2013). 
Structural and functional insight into an unexpectedly selective N-methyltransferase involved in plantazolicin 
biosynthesis. Proceedings of the National Acadmy of Sciences of the United States of America, 110 (32), 12954-
12959. 
 
Hao, Y., Blair, P. M., Sharma, A., Mitchell, D. A., & Nair, S. K. (2015). Insights into methyltransferase specificity 
and bioactivity of derivatives of the antibiotic plantazolicin. ACS Chemical Biology, 10 (5), 1209-1216.	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terminal α-amine completely loses its activity against Bacillus anthracis (Molohon, et al., 2011). 
A SAM-dependent methyltransferase L (BamL) identified in the PZN gene cluster of Bacillus 
amyloliquefaciens FZB42 is proposed to catalyze the dimethylation reaction on the peptide 
substrate (Fig. 3.1 A). 
The dimethylation of the N-terminal α-amine of a ribosomal peptide is unusual in bacteria. 
The only other examples observed to date are in the biosynthesis of linaridins, including 
cypemycin and grisemycin  (Claesen & Bibb, 2010; Claesen & Bibb, 2011). Both of them 
contain Nα, Nα-dimethyl-alanine at N-terminus and the lack of this modification also abolishes 
the bioactivity (Claesen & Bibb, 2011). Biochemical studies on the N-methyltransferase CypM 
in cypemycin biosynthesis showed that CypM is very promiscuous towards peptide substrate. It 
dimethylates the α-amine of small polar or nonpolar amino acids at N-terminus, and also the ε-
amine of an exposed Lys in the peptide (Zhang & van der Donk, 2012). In contrast to CypM, 
BamL requires the presence of both the N-terminal Arg and the following polyazolic structure to 
be catalytically competent. The substitution of Arg with homoarginine, ornithine, Lys or other 
representative amino acids didn’t trigger methylation reaction (Piwowarska, Banala, Overkleeft, 
& Süssmuth, 2013). The same goes for the replacement of the polyazole with small nonpolar 
residues, noncyclized precursors, or the heterocyle mimic Pro (Lee, et al., 2013). The single 
successful attempt in generating substrate analog was to keep the Arg and shorten the length of 
the polyazolic structure. BamL could effectively dimethylate the synthetic desmethylPZN 
analogs with 5 azoles (pentazole), 3 azole (triazole) and even 1 azole (monoazole) (Piwowarska, 
Banala, Overkleeft, & Süssmuth, 2013). It also works on Arg amide, but only under single 
turnover condition. 
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The stringent substrate requirement makes us wonder what are the structural differences 
between BamL and typical methyltransferases and what are the key elements in determining 
substrate recognition. To answer these questions, a structure of BamL in complex with its 
cognate substrate is desired. However, the attempt on co-crystallization was not successful due to 
the poor aqueous solubility of desmethylPZN. Obtaining substrate affinity to BamL or kinetic 
parameters for the methylation reaction was also impeded. Fortunately the more soluble 
monoazolic, triazolic and pentazolic desmethylPZN analogs (Arg-Az1, Arg-Az3 and Arg-Az5, 
respectively) (Fig. 3.1 C) were synthesized and showed low micromolar binding affinity to the 
enzyme (Sharma, Blair, & Mitchell, 2013). These analogs were used for co-crystallization with 
BamL as well as BpumL, the PZN methyltransferase from Bacillus pumilus ATCC7061, which 
shares 48% sequence identity with BamL. Here I reported the high-resolution structures of BamL 
in complex with S-adenosylhomocysteine (SAH) alone or in complex with both SAH and Arg-
Az1/Arg-Az3. I also presented the co-crystal structures of BpumL with SAH or with SAH and 
Arg-Az1/Arg-Az3/Arg-Az5. These truncated analogs also facilitated the kinetic parameter 
determination of both wide-type enzyme and active site mutants designed based on structure 
information. 
 
Experimental Procedures 
Cloning, Protein Expression and Purification 
The bamL gene from plantazolicin gene cluster of Bacillus amyloliquefacians FZB42 was 
cloned and ligated into pET-MBP vector, which is modified from commercial pET-28b vector 
(Novagen). The resulting recombinant BamL was fused to the C-terminus of the maltose binding 
protein (MBP) and a tobacco etch virus protease (TEV) recognition site between them is used for 
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cleavage. This plasmid pET-MBP-BamL was transformed into Rosetta 2 strain for expression. 
The culture first grew at 37 °C in LB medium supplemented with 50 µg/mL kanamycin and 25 
µg/mL chloramphenicol until O.D.600 reached 0.5. Overexpression of MBP-BamL was induced 
with 0.3 mM IPTG at 18 °C for 20 h. Cells were pelleted by centrifugation at 3566 ×g for 25 
min (SORVALL RC-3B Plus), resuspended with harvest buffer (20 mM Tris pH 8.0, 500 mM 
NaCl, 10% glycerol) and lysed with French Press (AVESTIN EmulsiFlex-C5). The supernatant 
was collected by centrifugation at 23645 ×g for 1 h (Beckman J2-21M/E) and slowly loaded 
onto a 20 mL amylose column (NEB) pre-equilibrated with harvest buffer. After washing with 
the same buffer for 5 column volumes to remove impurities, MBP-BamL was eluted directly 
with MBP elution buffer (harvest buffer supplemented with 20 mM maltose). Protein purity was 
checked with SDS-PAGE and clean fractions were pooled. Protein solution was then treated with 
TEV protease at 4 °C overnight with the addition of 0.5 mM dithiothreitol (DTT). Protein 
solution was further loaded onto a 5 mL HisTrap FF colume (GE Healthcare Life Sciences) pre-
equilibrated with harvest buffer. After washing with the same buffer for 2 column volumes, the 
tag-free BamL was eluted with wash buffer (20 mM Tris, pH 8.0, 1 M NaCl, 5% glycerol, 30 
mM imidazole). The His-tagged MBP could be removed from the column with elution buffer (20 
mM Tris, pH 8.0, 1 M NaCl, 5% glycerol, 200 mM imidazole). The BamL fractions were 
concentrated and the buffer was changed back to harvest buffer while concentrating. 
The bpumL gene from plantazolicin gene cluster of Bacillus pumilus ATCC7061 was cloned 
and ligated into pET-28b vector between NdeI and XhoI sites. The resulting recombinant BpumL 
contained a cleavable N-terminal hexahistidine tag (His-tag). The plasmid transformation, 
heterologous expression and cell disruption procedures were the same as pET-MBP-BamL. The 
supernatant was loaded onto a 5 mL HisTrap FF column. After extensive washing with wash 
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buffer, the His-BpumL was eluted with elution buffer in a 0-100% linear gradient over 40 mL. 
The protein purity was checked by standard SDS-PAGE and the purer fractions were collected 
and subjected to tag cleavage by thrombin. The tag-free BpumL was further purified by size 
exclusion chromatography with a HiLoad 16/600 Superdex 75 pg column (GE Healthcare Life 
Sciences). The protein was stable in gel filtration buffer (20 mM HEPES pH 7.5, 100 mM KCl) 
and was concentrated for further use. SeMet incorporated BpumL was expressed and purified in 
a similar manner. 
 
Crystallization and Structure Determination 
A sitting drop vapor diffusion method was used for robotic crystallization condition 
screening. The initial hits were further optimized with hanging drop vapor diffusion method. A 
typical hanging drop was set up with 1 µL of protein-substrate complex mixed with 1 µL of 
precipitant solution and was equilibrated over a well containing the same solution at 4 °C (for 
BamL) or 9 °C (for BpumL). The concentrations used for BamL and BpumL were 10 mg/mL 
and 8 mg/mL, respectively. The SAM and SAH were purchased from Sigma and used at 2 mM 
for crystallization. The plantazolicin analogs Arg-Az1, Arg-Az3, and Arg-Az5 were courtesy of 
Prof. D. Mitchell lab (Sharma, Blair, & Mitchell, 2013) and were incubated with enzymes at 2 
mM prior to crystallization. Crystals of BamL-SAH grew in 100 mM NaOAc pH 4.6, 1.8-2.2 M 
(NH4)2SO4. Crystals of BamL-Arg-Az1-SAH grew in 100 mM MES pH 6.5, 200 mM 
(NH4)2SO4, 26-32% PEG5000MME. Crystals of BamL-Arg-Az3-SAH grew in 100 mM Bis-tris 
pH 5.5, 200 mM Li2SO4, 18-24% PEG3350. Crystals of BpumL or SeMet-incorporated BpumL 
with SAH grew in 100 mM HEPES pH 7.5, 200 mM NaCl, 18-24% PEG3350. Crystals of 
BpumL-Arg-Az1-SAH grew in 100 mM Tris pH 8.5, 200 mM MgCl2, 24% PEG4000. Crystals 
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of BpumL-Arg-Az3-SAM grew in 100 mM Tris pH 8.5, 200mM MgCl2/NaOAc, 20%-24% 
PEG3350/PEG4000/PEG8000. Crystals of BpumL-Arg-Az5-SAM grew in 100 mM Tris pH 8.5, 
200 mM MgCl2, 24-27% PEG4000. All the crystals were stepwise equilibrated into 
crystallization condition supplemented with 10% (v/v) glycerol for protection before flash-frozen 
in liquid nitrogen. 
All of the data sets were collected at Sector 21 ID LS-CAT (Advanced Photon Source, 
Argonne National Labs, Illinois) and integrated and scaled using HKL2000 (Otwinowski & 
Minor, 1997) or XDS (Kabsch, 2010). Initial crystallographic phases were determined by single-
wavelength anomalous diffraction method (SAD) with a five-fold redundant data set of SeMet 
BpumL. Heavy atom sites were located using the HySS, and refinement of heavy atom 
parameters in SHARP (Bricogne, Vonrhein, Flensburg, Schiltz, & Paciorek, 2003) yielded an 
initial figure of merit (FOM) of 0.293 to 3.2 Å resolution. Solvent flattening using DM further 
improved the quality of the initial map (FOM = 0.665). Although the map was of marginal 
quality, a few α helices could be identified and manually docked. Further building of this model 
with Parrot (Zhang, Cowtan, & Main, 1997) and Buccaneer (Cowtan, 2006) resulted in the 
addition of a few β strands but with minimal registry of the primary sequence. This partial model 
could be successfully used to find a molecular replacement solution for the 1.75 Å BamL data set. 
Automated and manual rebuilding yielded a nearly complete model. The crystallographic phases 
of BpumL and other protein-ligand complexes were determined by the molecular replacement 
method (McCoy, Grosse-Kunstleve, Adams, Winn, Storoni, & Read, 2007) in the Phenix suite 
(Adams, et al., 2011), using BamL as searching model. Rounds of manual rebuilding using 
COOT (Emsley & Cowtan, 2004) were interspersed with crystallographic refinement using 
REFMAC5 (Murshudov, et al., 2011) until the free R factor dropped below 0.30. The validity of 
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all models was routinely determined with PROCHECK (Laskowski, Rullmannn, MacArthur, 
Kaptein, & Thornton, 1996), MOLPROBITY (Chen, et al., 2010) and by using the free R factor 
to monitor improvements during building and crystallographic refinement. 
 
Kinetic Analysis of BamL and BpumL Methyltransferases 
Kinetic analysis of BamL and BpumL utilized an enzyme-coupled continuous 
spectrophotometric assay (Dorgan, et al., 2006). Reaction mixtures typically consisted of 50 mM 
Tris pH 7.8, 200 µM MnSO4, 5 µM E. coli pfs nucleosidase, 5 µM B. subtilis adenine deaminase, 
80 µM SAM, and varying concentrations of the Arg-Az1, Arg-Az3, and Arg-Az5. The reaction 
progress was monitored at 37 °C and utilized 0.5 µM of either wild-type MBP-BamL or BpumL. 
Concentrations for the mutant MBP-BamL were as follows: 1.4 µM R42A, 1.325 µM T38F, 1.34 
µM L132F, 1.36 µM L162F, and 1.8 µM Y182F. Reaction progress was monitored as changes in 
absorption at a wavelength of 265 nm. Initial velocity data were calculated and fitted to the 
Michaelis-Menten equation using the Origin software package (OriginLab). Due to absorption by 
the substrates at 265 nm, reaction using high concentrations (>80 µM) of substrates failed to 
yield reliable data. 
 
Purification of Coupling Enzymes for Kinetic Assay 
The E. coli pfs nucleosidase plasmid pQE60-pfs was a gift from Prof. J. Cronan. It contained 
a T5 promoter and DH5α strain was used for protein expression. The culture first grew at 37 °C 
in LB medium supplemented with 100 µg/mL ampcillin until O.D.600 reached 0.5. 
Overexpression of pfs was induced with 1 mM IPTG at 37 °C for 4 h. The cell harvest and 
disruption and protein purification were carried out in a manner similar to BpumL. The clean 
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fractions from affinity chromatography were pooled and dialyzed to storage buffer (20 mM Tris 
pH 7.5, 300 mM NaCl, 30% glycerol) overnight. The resulting enzyme was aliquoted, flash-
frozen and stored in -80 °C. 
The adenine deaminase gene from Bacillus subtilis was amplified and cloned into pET-MBP, 
modified from commercial pET-28b (Novagen). The resulting recombinant deaminase had a His-
tag and MBP-tag fused at its N-terminus. The heterologous expression, cell disruption and 
protein purification procedures were the same as BpumL. The clean fractions from affinity 
chromatography were pooled and dialyzed to storage buffer (20 mM Tris pH 7.5, 300 mM NaCl, 
30% glycerol) overnight. The resulting enzyme was aliquoted, flash-frozen and stored in -80 °C. 
The mass concentration of pfs and MBP-adenine deaminase were determined using Bradford 
protein assay and then converted to molar concentration. 
 
Results 
Structural Characterization of BamL and BpumL 
In order to investigate the unexpectedly high substrate selectivity, we determined the crystal 
structures of BamL with a resolution of 1.75 Å and BpumL with a resolution of 1.9 Å, each in 
complex with SAH. Both of the structures contain a typical Rossmann fold at the core similar to 
the architecture of other methyltransferases (Fig. 3.2 A, B). A seven-stranded β sheet is in the 
center surrounded by six α helices. BamL and BpumL share 48% primary sequence identity and 
their structures are also superimposable with a RMSD of 1.1 Å. Structural homology search of 
BamL against PDB identified the closest structure as the bacterial Hen1 methyltransferase 
domain (PDB 3JWG) with a RMSD of 2.5 Å over 174 aligned Cα and the hypothetical bacterial 
YecO protein (PDB 1IM8) with a RMSD of 2.9 Å over 194 aligned Cα. The structural homology 
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mainly results from the conserved Rossmann fold in methyltransferases despite the marginal 
similarity across the primary sequence. 
Unlike the architectures of typical small molecule methyltransferases, BamL and BpumL 
contain only the minimal characteristic structural features as methyltransferases without extra 
fold or domain. One molecule of SAH binds inside BamL in a pocket defined by S92 and F137 
along the sides and a loop S112–A114 across the top (Fig. 3.2 C). R42 and H131 coordinate the 
carboxylate group of the homocysteine moiety through hydrogen bonds. D91 provides additional 
interaction with the 2’ hydroxyl group of the ribose. N113 is in hydrogen-bonding distance with 
the amine group of the adenine ring. These residues are conserved in the plantazolicin N-
methyltransferases (Fig. 3.3), mutations of which significantly compromise the methyltransferase 
activity. Interestingly, the trajectory of the homocysteine moiety of SAH is not collinear with the 
adenine ring but curves to the interior of BamL due to the F21 and loop G68–Q71, which is the 
conserved GxG loop in SAH-binding site (Kozbial & Mushegian, 2005). Consequently, the 
electrophilic methyl group of SAM is positioned at the junction of the SAM-binding pocket and 
a long tunnel that runs to the surface of the protein. The wall of this tunnel is lined up with a 
series of hydrophobic residues including F21, Y33, T38, L132, L162, Y182, L183, Y187 and 
L258 (Fig. 3.2 E). These residues are highly conserved between BamL and BpumL, except that 
the L183 is replaced by I181 in BpumL. Most of them are also retained in other annotated PZN 
N-methyltransferases, indicating the existence and importance of the hydrophobic tunnel (Fig. 
3.3). Since the depth of the tunnel is sufficient for accommodating part of the desmethylPZN, it 
is proposed to be the substrate-binding tunnel. The pinch point of the tunnel is roughly 4 Å and 
barely fit any residues (Fig. 3.2 F). It greatly limits the substrate spectrum to peptides containing 
planar azole structures following the N-terminal Arg and explains why Ala, Cys or Pro 
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substitutions abolish the methyltransferase activity. The amine group of the Arg is thus believed 
to situated at the junction of this tunnel and the SAM-binding pocket together with the methyl 
group of SAM. Supporting this postulate, a shorter, perpendicular cavity is found here to fit the 
side chain of Arg. 
 
Kinetic Analysis of Truncated DesmethylPZN Analogs 
Initial attempt on kinetic study was hindered by the poor aqueous solubility of 
desmethylPZN until the better-behaved truncated desmethylPZN analogs were successfully 
synthesized chemically and shown high affinity to the enzyme (Sharma, Blair, & Mitchell, 2013). 
Together with the hypothesis that the substrate-binding tunnel only accommodates part of the 
desmethylPZN, we conducted kinetic analysis with each of the truncated substrate analogs Arg-
Az1, Arg-Az3 and Arg-Az5 using an enzyme coupled assay to continuously monitor SAH 
production (Fig. 3.4). The coupling enzymes E. coli SAH nucleosidase and B. subtilis adenine 
deaminase have a kcat of 35.2 ± 0.92 s-1 and 4.12 ± 0.10 s-1 respectively (Dorgan, et al., 2006), 
greater than that of the two enzymes assayed. Under the assay condition, BamL showed a 
catalytic efficiency (kcat/KM) of 3.46 × 103 M-1 s-1 for Arg-Az1, 5.75 × 103 M-1 s-1 for Arg-Az3 
and 7.53 × 103 M-1 s-1 for Arg-Az5, increasing with the number of heterocycles (Table 3.1). 
While the kcat for the three substrates are comparable, KM value decreases with the increasing 
length of the substrate, indicating tighter interactions between the enzyme and the longer 
substrate. BpumL was only assayed with Arg-Az3, displaying a catalytic efficiency of 6.38 × 103 
M-1 s-1 comparable to that of BamL with the same substrate. 
 
Co-crystal Structures of PZN Methyltransferases with Truncated Substrates 
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Based on the enzyme activity and high affinity to truncated desmethylPZN substrates, we 
conducted co-crystallization study of both BamL and BpumL with the three assayed substrates to 
gain structural insights for the strict substrate selectivity. To obtain substrate-bound ternary 
complex, BamL was incubated with SAH and Arg-Az1 or Arg-Az3 and BpumL with SAH and 
Arg-Az1 prior to co-crystallization. To obtain product-bound ternary complex, equal 
concentrations of SAM and Arg-Az3 or Arg-Az5 were incubated with BpumL according to the 
pseudo single-turnover assay of BamL with desmethylPZN, so that Me-Arg-Az3 or Me-Arg-Az5 
is expected in the structure together with SAH. The structures of BamL and BpumL in complex 
with SAH and either of the Arg-Az1 and Arg-Az3 were determined with a resolution between 1.5 
Å and 1.8 Å. The structure of BpumL with SAH and Arg-Az5 was obtained at 1.75 Å resolution. 
In the ternary structures, clear and continuous electron density was observed for the N-terminal 
Arg and all of the heterocycles of Arg-Az1 and Arg-Az3 in the immediate vicinity of SAH; yet 
only the first four out of the five heterocycles of Arg-Az5 in BpumL-Arg-Az5-SAH structure 
showed strong electron density with the C-terminal fifth ring displaying much weaker electron 
density. 
The structures of the ternary complexes didn’t show huge conformational changes in 
comparison with the BamL-SAH or BpumL-SAH discussed previously (Fig. 3.5 A, B; Fig. 3.6 
A-C). The architecture of the Rossmann fold shapes two main cavities: one cavity is the 
SAM/SAH-binding pocket that accommodates SAH in a bent pose; the second cavity, 
connecting the first cavity, is the polyazolic substrate-binding tunnel as predicted (Fig. 3.5 C, 
Fig. 3.6 D). This hydrophobic tunnel is formed by the capping helices of the Rossmann fold and 
is perpendicular to the central β sheet. The (poly)azolic substrate binds in the tunnel in an 
extended manner with the α-amine of N-terminal Arg positioned at the base of the tunnel. The 
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location of the α-amine is at the junction of the tunnel and the pocket and in proximity to the 
electrophilic methyl group of SAM, expected from the orientation of the SAH by-product. Two 
polar residues D34 and Y182 (BamL numbering) are in hydrogen-bonding distance with it and 
serve as potential active site bases for proton abstraction (Fig. 3.7 A, C; Fig. 3.8 A, C, E). The 
perpendicular cavity observed previously at the junction holds the side chain of Arg in a planar 
conformation through a combination of van der Waals interactions and hydrogen-bonding 
network. BamL residues L162 and Y187 establish one side of the cavity and a short 310 helix 
spanning F13–F137 defines the opposite boundary. The guanidinum group of Arg is in 
hydrogen-bonding interactions with the side chains of E161, Q186 and S190, and the main chain 
carbonyl group of Q186 (Fig. 3.7 B, D; Fig. 3.8 B, D, F). The dimensions of the cavity and its 
extensive interactions with the side chain of the N-terminal residue support the lack of BamL 
methyltransferase activity towards polyazolic substrates with Lys, ornithine or homoarginine 
substitution at this position. 
The polyazolic substrate-binding tunnel is established by a group of hydrophobic residues 
and backed by a long, bent α helix (Fig. 3.7 A-D, Fig. 3.8 A-F). The thiazole at position 2 and 
methyloxazole at position 3 of the substrate are surrounded by hydrophobic residues including 
Y33, L132, I141, V160, L162, Y182, L183 and Y187. The methyloxazole is also in van der 
Waals contacts with L132 and L258. There is not much interaction between the tunnel and the 
rest of the substrate, except that thiazole at position 4 is in van der Waals contact with L258 and 
methyloxazole at position 5 forms aromatic-aromatic interaction with Y247 of BpumL, which is 
not a conserved residue in BamL. The depth of the tunnel could well accommodate 4 azole rings 
with the fifth ring at the edge, which partially explains its weak electron density in the structure 
(Fig. 3.6 D). Predicted from the enzyme-substrate interactions, the substitution of either of the 
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two thiazoles by methyloxazole would lead to steric clashes and thus truncated desmethylPZN 
with Thr at position 2 or 4 won’t be favorable methyltransferase substrate. 
The attempt on crystallizing product-bound ternary complexes of BpumL under single 
turnover condition was successful and monomethylated product Me-Arg-Az3 or Me-Arg-Az5 
was clearly observed with SAH in the active site, with a nearly identical orientation with the 
corresponding desmethyl substrate (Fig. 3.8 C-F). The monomethylated α-amine group of Arg is 
situated in a relatively hydrophobic environment created by BpumL residues F20, L130 and 
L134. The dimensions of the pocket are sufficient to fit the dimethylation on Arg of the 
substrate. Two polar residues D33 and Y180 are in hydrogen-bonding distance with the α-amine 
as in the substrate-bound structures. 
 
Conformational Change of a Capping Loop upon Substrate Binding 
In BamL, the substrate-binding tunnel is covered by a flexible region of the enzyme spanning 
residues T244–A257, over the position of the third azole ring through the fifth azole ring. It is 
close to the C-terminus of the enzyme and links an α helix to the Rossmann fold core. In the 
absence of polyazolic substrate, this region is a flexible loop with no obvious interactions with 
other parts of the enzyme (Fig. 3.9 A). With the presence of Arg-Az1, residues G247–M255 
change to an α helix orthogonal to the helix it links, to better encapsulate the substrate (Fig. 3.9 
B). With the presence of Arg-Az3, only residues S245–G248 form a one-turn helix joining the 
helix it links with the remainder as a loop, since the lengthy substrate breaks the trajectory of the 
helix (Fig. 3.9 C). The result of this conformational change is the optimized placement of M255 
to facilitate the packing of C-terminal azole and the establishment of an appropriate hydrophobic 
pocket according to the length of the substrate. This polymorphic region is among the least 
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conserved regions in primary sequence alignment of the PZN methyltransferases with several 
missing the entire C-terminal extension (Fig. 3.3). 
 
Kinetic Analysis of Active Site Variants with Substrate Arg-Az3 
The ternary structures reported here reveal several residues potentially important for catalysis 
or substrate binding in the vicinity of the bound polyazolic substrate. Based on the structure, 
several site-specific BamL variants were generated for kinetic analysis with Arg-Az3 as substrate 
(Table 3.2). T38 is located in the aforementioned long, bent helix that supports the substrate-
binding tunnel and is in van der Waals contact with the first two azoles of the substrate. T38F 
mutant shows a 17-fold decrease in catalytic efficiency. Likewise, Phe substitution of L132 or 
L162 that are in contact with the first two azoles also leads to decreased catalytic efficiency by 
16 fold and 48 fold, respectively. In these cases, the replacement with bulkier Phe side chain 
potentially narrows the substrate-binding tunnel and creates steric clashes to restrict the access of 
substrate to the methylation site. Y182 is in hydrogen-bonding distance with the α-amine of the 
substrate and Y182F mutation results in a 17-fold decrease in catalytic efficiency, consistent with 
its potential role as an active site base for α-amine deprotonation. Y182 is not conserved in some 
annotated PZN methyltransferases. A Phe appears in this position in two of the transferases, but 
neighboring Tyr residues may play a similar role to Y182. Another residue R42 in coordinating 
the carboxyl group of SAH/SAM was also investigated by Ala substitution. Mutation R42A 
results in a decreased catalytic efficiency by 12 fold, indicating its importance in catalysis. 
 
Discussion 
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Plantazolicin is a linear azol(in)e-containing peptide produced by the plant growth-promoting 
rhizobacterium Bacillus amyloliquefaciens FZB42 (Scholz, et al., 2011). It is a narrow-spectrum 
antibiotic potently against the anthrax-causing pathogen Bacillus anthracis. The bioactivity of 
plantazolicin is heavily dependent on the dimethylation at the α-amine of the N-terminal Arg 
(Molohon, et al., 2011). The dimethylation is catalyzed by the N-methyltransferase BamL in the 
PZN gene cluster in a leader peptide independent manner, which requires either the precise 
recognition of substrate or broad substrate tolerance by the enzyme. The latter strategy is adopted 
by a previously reported linaridin N-methyltransferase CypM (Zhang & van der Donk, 2012), 
which dimethylates the α-amine of the N-terminal Ala in cypemycin biosynthesis. In contrast, 
biochemical studies showed that BamL is highly selective towards its cognate substrate, Arg 
with succeeding polyazole. Substitution of the azolic structure with any unmodified residue 
completely abolished the methyltransferase activity. Interestingly, BamL retains 
methyltransferase activity towards truncated desmethylPZN analogs, Arg-Az5, Arg-Az3, and 
Arg-Az1. It even catalyzes methylation of Arg amide. The kinetic studies presented here 
demonstrated that the truncated desmethylPZN analogs are tightly bound substrates with low-
micromolar affinity and are effectively turned over by BamL and BpumL with comparable kcat. 
The KM showed a decreasing trend with increasing numbers of azole rings, indicating the 
possible involvement of all five azoles in enzyme-substrate interactions. Although Arg and the 
first azole ring already guarantee the substrate binding, the presence of the rest four azoles 
doubles the substrate affinity. To gain insights in the structural basis of this unusual substrate 
specificity, the co-crystallization of BamL in complex with SAH and truncated desmethylPZN 
analogs were attempted and reported here, despite the failure in co-crystallization with the native 
substrate desmethylPZN. 
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The BamL overall structure, as well as the structure of its homolog BpumL, appears as a 
minimal Rossmann fold typical in SAM-dependent methyltransferases. Unlike most small 
molecule methyltransferases, BamL contains no elaborated auxiliary folds for substrate 
recognition. SAH is coordinated mainly through hydrogen bonds in the binding pocket, with the 
homocysteine moiety bent towards the interior of BamL. The structure feature that determines 
the substrate selectivity is the deep, narrow, hydrophobic substrate-binding tunnel formed by the 
capping helices of the Rossman fold. The tunnel is perpendicular to the central β sheet and runs 
from the surface to the interior of the protein. It connects the SAH/SAM-binding pocket at the 
base and an additional narrow cavity protrudes perpendicularly at the joint. 
In the co-crystal structure of BamL/BpumL with the truncated substrate analogs, the planar 
azolic substrate is tightly situtated in the aforementioned hydrophobic tunnel, with the side chain 
of N-terminal Arg fits in the perpendicular narrow cavity. The effective substrate binding is 
made through the extensive hydrophobic interactions with the polyazolic structure and the 
hydrogen-bonding interactions with Arg side chain. Fist, the dimension of the substrate-binding 
tunnel substantially restricts the access to catalytic site by peptides with unmodified residues. 
The steric restrains created by the residues lining the tunnel would energetically disfavor the 
accommodation of these substrates unless considerable conformational changes occur in the 
enzyme. Also, as indicated by the kinetic analysis of BamL mutants, the dimensions of the tunnel 
are precisely designed for the restrained planar polyazolic substrate. The native substrate would 
also be blocked if the tunnel is further narrowed by introduction of bulkier residues on the wall. 
Second, the residues lining the substrate-binding tunnel are mainly hydrophobic, which prefers 
the placement of hydrophobic substrate in the tunnel. Any charges or polar groups would be 
unfavorable. This provides an additional explanation for the selectivity towards polyazolic 
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substrate, because heterocyclized residues are apparently less hydrophilic compared with their 
unmodified counterparts. It also rationalizes the result that Arg thiazole with a terminal amide is 
the minimal BamL substrate (Piwowarska, Banala, Overkleeft, & Süssmuth, 2013) and that Arg 
amide is only turned over under single-turnover condition. In contrast, the free amino acid Arg, 
bearing a carboxylate group, is not accepted as a substrate, despite the satisfaction of steric 
requirement. Last, the side chain of N-terminal Arg fits tightly in the cavity perpendicular to the 
substrate tunnel. The guadinino group at the base of the cavity forms hydrogen bonds with D161 
and S190, as well as the backbone carbonyl group of Q186. This extensive hydrogen-bonding 
network observed both in BamL and BpumL co-crystal structures justifies the strict requirement 
of Arg at N-terminus of the substrate. Substitution with either ornithine or Lys disrupts the 
contacts and results in poor substrate. Similarly, homoArg substitution results in an extra 
methylene group in side chain that fails to meet the steric limitation of the cavity. 
At the joint of the SAH/SAM-binding pocket and substrate-binding tunnel, the S atom of 
SAH and the α-amine are located in proximity to each other. BamL residues D34 and Y182 are 
in hydrogen-bonding distance to the α-amine and likely facilitate the methyltransferase reaction 
by deprotonating the α-amine. Mutation Y182 to Phe significantly impedes the catalytic 
efficiency of BamL. Interestingly, Phe naturally occurs in two BamL homologs CurL and BlinL, 
which indicates a similar role may be played by other residues in the vicinity, such as the Y21 
compared to F21 in BamL. The catalytic cycle is thus proposed as following (Fig. 3.10). A base 
at active site deprotonates the α-amine of the bound substrate and facilitates its nucleophilic 
attack onto the methyl group of SAM. The resulting SAH is then replaced by a second molecule 
of SAM. The monomethylated α-amine is further deprotonated and methylated to the 
dimethylated α-amine, which is less favored in the hydrogen-bonding network. The increased 
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hydrophobicity of the product disfavors binding in the catalytic site and enables the release of the 
product. 
In summary, the co-crystal structures of BamL/BpumL with the truncated desmethylPZN 
analogs elucidate the strict substrate selectivity of plantazolicin methyltransferase. PznL is 
designed with such structural features that it does not “cross-react” with other peptide substrates, 
nor disturb other cellular processes. It is specifically expressed for a single purpose and not 
exploited by other processes, ensuring efficient plantazolicin production. The structure 
information also provides clues for rational engineering of plantazolicin. The substrate-binding 
tunnel forms extensive interactions mainly with the first five or six residues of the substrate and 
the rest of the residues are exposed. Substituting these residues or modifying the length of the 
substrate would be a feasible method to generate plantazolicin library for bioactivity assessment. 
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Figures 
 
 
 
Fig. 3.1    A. Plantazolicin biosynthetic gene cluster from Bacillus amyloliquefaciens FZB42. 
bamA encodes the precursor peptide; bamD encodes the heterocyclase (cyclodehydratase) and 
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bamC encodes the docking protein; bamB encodes the FMN-dependent dehydrogenase; product 
of bamE is a zinc-dependent protease; bamL encodes the SAM-dependent methyltransferase; 
bamF is a immunity gene; bamK encodes a transcriptional regulator; bamGH encode ABC 
transporter. B. The general biosynthetic pathway of plantazolicin. Precursor peptide BamA 
undergoes cyclodehydration and oxidation by BamBCD complex to form two patches of poly 
azol(in)e. Removal of the leader peptide generates a N-terminal amine. It is dimethylated by 
BamL and the resulting PZN is in active form. C. Synthetic desmethylPZN analogs, Arg-Az1, 
Arg-Az3, and Arg-Az5. They bind BamL with low micromolar affinity and can be converted by 
dimethylated products by BamL. 
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Fig. 3.2    A. Overall structure of BamL in complex with SAH. SAH, shown as sticks, is located 
in a pocket in the Rossmann fold. B. Overall structure of BpumL in complex with SAH. SAH, 
shown as sticks is located in a pocket in the Rossmann fold. C. Coordination of SAH in the 
binding pocket of BamL. The 2Fo-Fc map is shown with the stick representation of SAH (green). 
BamL BpumL 
A B 
C D 
	  180° 
E F 
4Å 
	   87	  
The map contoured at 1.5σ is shown in gray and the map contoured at 4σ is shown in red. BamL 
residues R42 and H131 form hydrogen bonds with the carboxylate group of homocysteine of 
SAH. D91 interacts with the 2’ hydroxyl group of the ribose moiety. N113 interacts with the 
adenine ring through hydrogen bonds. The conserved GxG motif in SAH/SAM-binding pocket 
of SAM-dependent methyltransferases is highlighed in yellow. D. Coordination of SAH in the 
binding pocket of BpumL. The 2Fo-Fc map is shown with the stick representation of SAH 
(green). The map contoured at 1.5σ is shown in gray and the map contoured at 4σ is shown in red. 
BpumL residues R41 and H129 form hydrogen bonds with the carboxylate group of 
homocysteine of SAH. D90 interacts with the 2’ hydroxyl group of the ribose moiety. D112 
interacts with the adenine ring through hydrogen bonds. The conserved GxG motif in 
SAH/SAM-binding pocket of SAM-dependent methyltransferases is highlighed in yellow. E. A 
tunnel in BamL lined with hydrophobic residues is connected to the SAH-binding pocket and the 
joint is at the position of the methyl group of SAM. Another cavity protrudes from the joint, 
perpendicular to the hydrophobic tunnel. F. The hydrophobic tunnel runs to the surface of the 
BamL and is relatively narrow. The dimension of the pinch point is about 4 Å. 
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Fig. 3.3    Sequence alignment of the annotated plantazolicin methyltransferases PznLs from 
different bacteria. BamL is from Bacillus amyloliquefaciens FZB42; BpumL is from Bacillus 
pumilus ATCC7061; CmsL is from Clavibacter michiganensis subsp. sepedonicus; CurL is from 
Corynebacterium urealyticum DSM 7109; BlinL is from Brevibacterium linens BL2. Residues 
important for SAH/SAM binding are indicated with purple arrowheads. Residues involved in 
polyazolic substrate coordination are indicated with green arrowheads. 
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Fig. 3.4    Michaelis-Menten curves of BamL assayed with truncated PZN analogs as substrates. 
The co-substrate SAM is provided at 80 µM, which is 10 × Kd calculated from the isothermal 
titration calorimetry measurement. The coupling enzyme pfs nucleosidase cleaves the SAH 
product into adenine and S-ribosyl homocysteine. The former one is further converted to 
hypoxanthine by adenine deaminase, coupled with a decrease of absorption at 265 nm. This 
correlation between absorption change and SAH generation allows for the calculation of SAH 
produced in the reaction, which is then correlated to the production of dimethylated PZN 
analogs. 
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Fig. 3.5    A. Co-crystal structure of BamL with SAH (gray sticks) and Arg-Az1 (green sticks). 
B. Co-crystal structure of BamL with SAH (gray sticks) and Arg-Az3 (green sticks). C. SAH 
(cyan) and Arg-Az3 (green) shown in the BamL SAH/SAM-binding pocket and substrate-
binding tunnel, respectively. The α-amine of the N-terminal Arg is in proximity to the S of SAH, 
and potentially the methyl group of SAM. The Arg side chain is accommodated in the 
perpendicular cavity. The planar polyazolic substrate fits properly in the narrow tunnel. 
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Fig. 3.6    A. Co-crystal structure of BpumL with SAH (gray sticks) and Arg-Az1 (green sticks). 
B. Co-crystal structure of BpumL with SAH (gray sticks) and Me-Arg-Az3 (green sticks). C. Co-
crystal structure of BpumL with SAH (gray sticks) and Me-Arg-Az5 (green sticks). D. SAH 
(cyan) and Me-Arg-Az5 (green) shown in the BpumL SAH/SAM-binding pocket and substrate-
binding tunnel, respectively. The monomethylated α-amine of the N-terminal Arg is in proximity 
to the S of SAH, and potentially the methyl group of SAM. The Arg side chain is accommodated 
in the perpendicular cavity. The planar polyazolic substrate fits properly in the narrow 
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hydrophobic tunnel. The depth of the tunnel fits the first four azole rings and thus the fifth ring is 
exposed to solvent, making almost no contact with the enzyme. Based on the co-crystal structure, 
only the first polyazole patch interacts with the enzyme and the following residues are fully 
exposed to solvent. The flexibility of the second half of desmethylPZN is one possible reason for 
the failure of co-crystallization with full-length desmethylPZN. 
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Fig. 3.7    A. Coordination of Arg-Az1 (green sticks) in the substrate-binding tunnel of BamL. 
The 2Fo-Fc map of Arg-Az1 contoured at 1.5σ is shown in gray and the map contoured at 4σ is 
shown in red. Arg-Az1 is coordinated by a cluster of hydrophobic residues in the tunnel. SAH is 
shown as gray sticks. B. LIGPLOT diagram (Laskowski & Swindells, 2011) showing the 
interactions between BamL and Arg-Az1 (purple). Carbon, oxygen, nitrogen and sulfur atoms are 
colored in black, red, blue and yellow, respectively. Hydrogen bonds are shown in dashed green 
lines with indicated bond lengths. Hydrophobic interactions are shown as red arcs with radiating 
A 
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spikes. C. Coordination of Arg-Az3 (green sticks) in the substrate-binding tunnel of BamL. The 
2Fo-Fc map of Arg-Az3 contoured at 1.5σ is shown in gray and the map contoured at 4σ is 
shown in red. Arg-Az3 is coordinated by a cluster of hydrophobic residues in the tunnel. SAH is 
shown as gray sticks. D. LIGPLOT diagram (Laskowski & Swindells, 2011) showing the 
interactions between BamL and Arg-Az3 (purple). Carbon, oxygen, nitrogen and sulfur atoms are 
colored in black, red, blue and yellow, respectively. Hydrogen bonds are shown in dashed green 
lines with indicated bond lengths. Hydrophobic interactions are shown as red arcs with radiating 
spikes. 
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Fig. 3.8    A. Coordination of Arg-Az1 (green sticks) in the substrate-binding tunnel of BpumL. 
The 2Fo-Fc map of Arg-Az1 contoured at 1.5σ is shown in gray and the map contoured at 4σ is 
shown in red. Arg-Az1 is coordinated by a cluster of hydrophobic residues in the tunnel. SAH is 
shown as gray sticks. B. LIGPLOT diagram (Laskowski & Swindells, 2011) showing the 
interactions between BpumL and Arg-Az1 (purple). Carbon, oxygen, nitrogen and sulfur atoms 
are colored in black, red, blue and yellow, respectively. Hydrogen bonds are shown in dashed 
green lines with indicated bond lengths. Hydrophobic interactions are shown as red arcs with 
radiating spikes. C. Coordination of Me-Arg-Az3 (green sticks) in the substrate-binding tunnel of 
BpumL. The 2Fo-Fc map of Me-Arg-Az3 contoured at 1.5σ is shown in gray and the map 
contoured at 4σ is shown in red. Me-Arg-Az3 is coordinated by a cluster of hydrophobic residues 
in the tunnel. SAH is shown as gray sticks. D. LIGPLOT diagram (Laskowski & Swindells, 2011) 
showing the interactions between BpumL and Me-Arg-Az3 (purple). Carbon, oxygen, nitrogen 
A 
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and sulfur atoms are colored in black, red, blue and yellow, respectively. Hydrogen bonds are 
shown in dashed green lines with indicated bond lengths. Hydrophobic interactions are shown as 
red arcs with radiating spikes. E. Coordination of Me-Arg-Az5 (green sticks) in the substrate-
binding tunnel of BpumL. The 2Fo-Fc map of Me-Arg-Az5 contoured at 1.5σ is shown in gray 
and the map contoured at 4σ is shown in red. Me-Arg-Az5 is coordinated by a cluster of 
hydrophobic residues in the tunnel. SAH is shown as gray sticks. F. LIGPLOT diagram 
(Laskowski & Swindells, 2011) showing the interactions between BpumL and Me-Arg-Az5 
(purple). Carbon, oxygen, nitrogen and sulfur atoms are colored in black, red, blue and yellow, 
respectively. Hydrogen bonds are shown in dashed green lines with indicated bond lengths. 
Hydrophobic interactions are shown as red arcs with radiating spikes. 
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Fig. 3.9    A. A polymorphic region (blue) in BamL forms a loop and caps the hydrophobic 
substrate-binding tunnel in the absence of substrate. B. The polymorphic region (blue) in BamL 
forms an α helix in the presence of Arg-Az1. C. The polymorphic region (blue) in BamL forms a 
one-turn α helix in the presence of Arg-Az3 with the movement M265 to accommodate the 
substrate. 
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Fig. 3.10    Proposed mechanism of plantazolicin methyltransferase reaction. A base at active site 
deprotonates the α-amine of the N-terminal Arg of the polyazolic substrate and facilitates its 
nucleophilic attack onto the methyl group of SAM. Product SAH is then displaced by a second 
molecule of SAM. The monomethylated α-amine is further deprotonated and performs the 
second nucleophilic attack to form the dimethylated product. 
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Tables 
 
Table 3.1    Steady-State Kinetic Parameters for BamL and BpumL with Truncated 
DesmethylPZN Analogs 
 
BamL KM (10-6 M) kcat (10-2 s-1) kcat/KM (M-1 s-1) 
Arg-Az1 26.8 ± 3.3   9.3 ± 0.4 3.46 × 103 
Arg-Az3 18.3 ± 0.5 10.5 ± 0.1 5.75 × 103 
Arg-Az5 14.6 ± 2.0 11.0 ± 0.4 7.53 × 103 
Arg-Az3 (BpumL) 22.5 ± 2.3 14.4 ± 0.7 6.38 × 103 
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Table 3.2    Steady-State Kinetic Parameters for BamL Variants against Arg-Az3 
 
BamL kcat/KM (M-1 s-1) 
Wild-type 57.5 × 102 
T38F   3.3 × 102 
R42A   4.7 × 102 
L132F   3.5 × 102 
L162F   1.2 × 102 
Y182F   1.7 × 102 
 
 
	   101	  
Chapter 4    Structural Studies on the Prenyltransferases in Cyanobactins Biosynthesis 
 
Introduction 
Natural products are good sources for drug discovery and provide chemists with scaffolds for 
further improvement or novel design. A majority of natural products are, however, challenging 
for synthesis and thus the exploitation and optimization of their original biosynthetic pathways 
are promising approaches for generating unnatural variants. Synthetic biologists have developed 
strategies for in vivo production of various classes of natural products and one substantially 
explored class is cyanobactins (Tianero, Donia, Young, Schultz, & Schmidt, 2012; Ruffner, 
Schmidt, & Heemstra, 2015). Cyanobactins are ribosomally synthesized and post-translationally 
modified peptides (RiPP) (Arnison, et al., 2013) and generally contain multiple heterocycles 
within a macrocyclic structure (Donia, et al., 2006; Donia, Ravel, & Schmidt, 2008; Sivonen, 
Leikoski, Fewer, & Jokela, 2010) (Fig. 4.1 A). The enzymatic mechanisms of heterocycle 
installation and macrocycle formation are thoroughly investigated and demonstrate strict 
dependency on the interaction between enzymes and recognition sequences harbored in the 
precursor peptide, similar to other typical RiPP modification reactions (McIntosh & Schmidt, 
2010; McIntosh, Donia, & Schmidt, 2010; Agarwal, Pierce, McIntosh, Schmidt, & Nair, 2012; 
Koehnke J. , et al., 2012; Koehnke J. , et al., 2013; Sardar, Pierce, McIntosh, & Schmidt, 2015). 
In comparison, these tailoring enzymes are rather promiscuous towards the core peptides under 
modification, since cyanobactin precursor peptide naturally bears multiple copies or variants of 
core peptides (Donia, Ravel, & Schmidt, 2008; Donia & Schmidt, 2011). This substrate tolerance 
provides the opportunity for the establishment of a library of cyanobactin variants. Some 
cyanobactins further undergo additional modifications after macrocyclization, independent of the 
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recognition sequences. One commonly occurred decoration is prenylation with isoprenoids, such 
as dimethylallyl group or geranyl group (McIntosh, Donia, Nair, & Schmidt, 2011). This 
modification increases the lipophilicity of peptide products and could potentially confer other 
functions or preferable features as drug candidates. However, the substrate recognition and 
reaction mechanism of this process is still elusive. 
Prenylation modification occurs in diverse biological processes of both prokaryotic and 
eukaryotic organisms. It is a common and important modification on eukaryotic proteins 
involved in essential cellular pathways. It facilitates membrane anchorage of the modified 
protein, alter its function and localization, and initiate cellular signaling transduction (Hannoush 
& Sun, 2010; Zverina, Lamphear, Wright, & Fierke, 2012). Most protein prenylations in 
eukaryotes involve farnesyl (C15) or geranylgeranyl (C20) group and the mechanisms of 
corresponding prenyltransferases have been comprehensively studied (Liang, Ko, & Wang, 
2002; Palsuledesai & Distefano, 2015). Prenylation of small molecules is an essential 
biosynthetic step for some secondary metabolites, and for other metabolites, a crucial 
modification to confer bioactivity, product diversity and lipophilicity (Tello, Kuzuyama, Heide, 
Noel, & Richard, 2008; Heide, 2009). The small molecules undergoing modification and the 
types of isoprenoids used are more diverse than that in protein prenylation reactions. The 
corresponding prenyltransferases attract the attention of researchers due to the substrate 
promiscuity and potential biotechnological applications. Prenyltransferases that modify peptide 
substrates are less common and insufficiently investigated, though. One notable example is the 
Bacilli geranyl/farnesyl transferase ComQ involved in the biosynthesis of quorum-sensing 
peptide ComX (Magnuson, Solomon, & Grossman, 1994). It geranylates/farnesylates the indole 
ring of Trp similar to some small molecule prenyltransferases but displays strong dependency on 
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the sequence of flanking peptides (Tsuji, et al., 2012). The other example is the cyanobactin 
prenyltransferases discussed here, which select both the substrate residue and the flanking 
residues. Investigation on enzymatic mechanism and substrate preference is of great value in 
further expanding the cyanobactin library and generating non-cyanobactin peptides with 
isoprenoid modifications. 
Genome mining of cyanobactin biosynthetic clusters led to the discovery of putative 
prenyltransferases with predicted isoprenoid-modified products isolated (Donia & Schmidt, 
2011; Leikoski, et al., 2013). Despite the lack of sequence similarity with representative 
prenyltransferases, these proteins are postulated to utilize short isoprenoids (C5 or C10) and 
catalyze forward (attachment made through C1 atom) or reverse (attachment through C3 atom) 
prenylation on the hydroxyl groups of Tyr or Ser/Thr (Fig. 4.1 B). LynF from Lyngbya aestuarii 
was the first in vitro investigated cyanobactin prenyltransferase. The reported catalytic 
mechanism and substrate tolerance validated its function as an O-prenyltransferase for a group of 
Tyr containing peptides beyond its cognate substrate, even including small molecules boc-L-Tyr 
and boc-D-Tyr (McIntosh, Donia, Nair, & Schmidt, 2011). It is obvious that there is no such 
recognition sequence requirement for prenylation reaction but certain unknown determinants are 
definitely indispensable. TruF from trunkamide biosynthetic pathway was proposed to reverse-
prenylate Ser/Thr (Donia, Ravel, & Schmidt, 2008). PirF from Microcystis aeruginosa PCC7005 
was speculated to add geranyl group to its substrates (Leikoski, Fewer, Jokela, Alakoski, 
Wahlsten, & Sivonen, 2012). However, no further mechanistic studies were so far reported to 
explain their substrate preference. The prenyltransferase gene even appears in the pat cluster that 
produces no prenylated cyanobactins (Schmidt, et al., 2005). The structure of the putative 
prenyltransferase PatF was reported previously but provided limited information on its catalytic 
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deficiency with tested substrates (Bent, Koehnke, Houssen, Smith, Jaspars, & Naismith, 2013). 
Recent bioinformatic study revealed a new group of short, linear cyanobactins that are prenylated 
on N-terminal α-amine and methylated on C-terminal carboxyl group by a methyltransferase-
prenyltransferase fusion protein, which displays a different substrate spectrum compared to the 
classic cyanobactin prenyltransferases (Leikoski, et al., 2013). The substrate selectivity and 
catalytic promiscuity of cyanobactin prenyltransferases allow these enzymes to be potential tools 
for enzymatic attachment of isoprenoids onto peptides. Therefore the mechanism and substrate 
tolerance study would be required. 
To gain insights in the reaction mechanism and substrate specificity of cyanobactin 
prenyltransferases, co-crystal structures with prenyl donor analog and linear or macrocyclic 
substrates were determined for PagF in the prenylagaramide (pag) gene cluster from Oscillatoria 
agardhii. PagF reveals an α/β barrel structure reminiscent of the bacterial ABBA family aromatic 
prenyltransferases. Both of the prenyl donor and acceptor bind inside the barrel for catalysis. A 
peptide as prenyl acceptor is required to exclude solvent molecules from active site channel, 
prevent quenching the reactive carbocation intermediate, and ensure productive prenylation 
reaction. Primary sequence analysis on the annotated cyanobactin prenyltransferases explains the 
lack of activity for PatF in the patellamide gene cluster and provides clues on distinguishing 
functional prenyltransferases from incompetent ones. The putatively active ThcF in 
cyanothecamide gene cluster from Cyanothece sp. PCC7425 and PirF in piricyclamide gene 
cluster from Microcystis aeruginosa PCC7005 were tested for activity and confirmed as Tyr 
prenyltransferase and Tyr geranyltransferase, respectively. The native structure of PirF was 
determined to further justify that cyanobactin prenyltransferases adopt a solvent-exposed open 
channel to accommodate peptide substrates. 
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Experimental Procedures 
Cloning, Protein Expression and Purification 
The pagF gene from prenylagaramide (pag) gene cluster of Oscillatoria agardhii was cloned 
and ligated into pET-28b vector (Novagen). The resulting recombinant PagF contained a 
cleavable N-terminal hexahistidine tag (His-tag). This plasmid pET28-PagF was transformed 
into Rosetta 2 strain for expression. The culture first grew at 37 °C in LB medium supplemented 
with 50 µg/mL kanamycin and 25 µg/mL chloramphenicol until O.D.600 reached 0.5. 
Overexpression of His-PagF was induced with 0.3 mM IPTG at 18 °C for 20 h. Cells were 
pelleted by centrifugation at 3566 ×g for 25 min (SORVALL RC-3B Plus), resuspended with 
harvest buffer (20 mM Tris pH 8.0, 500 mM NaCl, 10% glycerol) and lysed with French Press 
(AVESTIN EmulsiFlex-C5). The supernatant was collected by centrifugation at 23645 ×g for 1 
h (Beckman J2-21M/E) and loaded onto a 5 mL HisTrap FF column pre-equilibrated with wash 
buffer (20 mM Tris, pH 8.0, 1 M NaCl, 5% glycerol, 30 mM imidazole). After washing with the 
same buffer for 5 column volumes to remove impurities, the His-PagF was eluted with elution 
buffer (20 mM Tris, pH 8.0, 1 M NaCl, 5% glycerol, 200 mM imidazole) in a 0-100% linear 
gradient over 40 mL. Protein purity was checked with SDS-PAGE and clean fractions were 
pooled. Protein solution was then treated with thrombin at 4 °C overnight to remove the His-tag. 
The tag-free PagF was further purified by size exclusion chromatography with a HiLoad 16/600 
Superdex 75 pg column (GE Healthcare Life Sciences). The protein was stable in gel filtration 
buffer (20 mM Tris pH 7.5, 100 mM KCl) and was concentrated for further use. 
The thcF gene from cyanothecamide gene cluster of Cyanothece sp. PCC7425 was cloned 
and ligated into pET-28b vector (Novagen). The resulting recombinant ThcF contained a 
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cleavable N-terminal hexahistidine tag (His-tag). The plasmid transformation, heterologous 
expression and cell disruption procedures were the same as pET28-PagF. The His-ThcF was 
purified with immobilized metal ion affinity chromatography (IMAC) as described in PagF 
purification. The protein purity was checked by standard SDS-PAGE and clean fractions were 
collected. The His-ThcF was further purified by size exclusion chromatography with a HiLoad 
16/600 Superdex 75 pg column (GE Healthcare Life Sciences). The protein was stable in gel 
filtration buffer (20 mM Tris pH 8.0, 500 mM KCl) and was concentrated for further use. 
The codon optimized pirF gBlock gene fragments from Microcystis aeruginosa PCC7005 
was purchased from Integrated DNA Technologies Inc. It was amplified by PCR and cloned into 
pET-28b vector between NdeI and XhoI sites. The resulting recombinant PirF contained a 
cleavable N-terminal hexahistidine tag (His-tag). The heterologous expression and protein 
purification procedures were the same as pET28-PagF, except that the final gel filtration buffer is 
20 mM HEPES pH 7.5, 500 mM KCl. The protein was concentrated and flash-frozen in liquid 
nitrogen for storage. 
 
Crystallization and Structure Determination 
A sitting drop vapor diffusion method was used for robotic crystallization condition 
screening. The initial hits were further optimized with hanging drop vapor diffusion method. A 
typical hanging drop was set up with 1 µL of protein mixed with 1 µL of precipitant solution and 
was equilibrated over a well containing the same solution at 9 °C. HEPES buffer was avoided in 
PagF crystallization since the buffer molecule binds in the substrate-binding channel. Ball-like 
crystals of PagF were able to grow at a protein concentration of 21 mg/mL and in 20 mM Tris 
pH 7.5, 200 mM NaCl, 24% PEG3350. The crystal form didn’t change until additives (Hampton 
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Research) were introduced in the hanging drops. The thin needle-like PagF crystals were 
equilibrated into crystallization condition supplemented with 12% (v/v) PEG3350 for protection 
before flash-frozen in liquid nitrogen. To obtain enzyme-substrate complex, the native PagF 
crystals were soaked in crystallization solution supplemented with 4 mM DMSPP, 10 mM 
MgCl2, and 10 mM boc-L-Tyr, or 20 mM Tyr-Tyr-Tyr, or 100 µM cyclic[INPYLYP], for 4 h, 22 
h, 41 h, respectively. All three peptides were gifts from Prof. E. Schmidt lab (University of Utah, 
Utah). 
PirF crystals suitable for diffraction were obtained with hanging drop vapor diffusion 
method. 1 µL of 8 mg/mL PirF was mixed with 1 µL of precipitant solution (100 mM Bis-tris 
propane pH 7.0, 100 mM (NH4)2SO4, 1 M sodium citrate tribasic dihydrate) and equilibrated 
over a well containing the same solution at 9 °C. The plate-like crystals were equilibrated into 
crystallization condition supplemented with 25% (w/v) threitol or trehalose for protection before 
flash-frozen in liquid nitrogen. 
All of the data sets were collected at Sector 21 ID LS-CAT (Advanced Photon Source, 
Argonne National Labs, Illinois) and integrated and scaled using HKL2000 (Otwinowski & 
Minor, 1997) or XDS (Kabsch, 2010). Initial crystallographic phases of PagF were determined 
by single-wavelength anomalous diffraction method (SAD). A twelve-fold redundant data set 
from crystals soaked with trimethyl lead acetate was collected at lead absoption edge to a 
resolution of 2.65 Å. Heavy atom sites were located using HySS and refined using Phaser in the 
Phenix suite (Adams, et al., 2011), yielding an figure of merit (FOM) of 0.462. This initial map 
allowed the automatic building of most of the main chains and over half of the side chains using 
ARP/wARP. This model was refined against higher resolution data using REFMAC5 
(Murshudov, et al., 2011) and further manually built using COOT (Emsley & Cowtan, 2004). 
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The free R factor was used to monitor building bias during building and crystallographic 
refinement (Kleywegt & Brünger, 1996). The diffraction data from crystals of PagF-ligand 
complexes were processed in a similar way. The phasess were determined using molecular 
replacement method with the refined ligand-free PagF structure as model (McCoy, Grosse-
Kunstleve, Adams, Winn, Storoni, & Read, 2007). The resultant solutions were further 
automatically built using ARP/wARP, followd by rounds of manual rebuilding using COOT and 
refinement using REFMAC5. The diffraction data from native PirF crystal was integrated and 
scaled with autoPROC (Vonrhein, et al., 2011). The initial phase was determined using 
molecular replacement method with refined ligand-free PagF structure as model (McCoy, 
Grosse-Kunstleve, Adams, Winn, Storoni, & Read, 2007). The resultant solution was 
automatically built using Autobuild and further refined with Phenix.refine in the Phenix suite 
(Adams, et al., 2011), followed by manual building using COOT and refinement using 
REFMAC5. 
 
Activity Analysis of ThcF and PirF 
Overnight reactions were set up at room temperature with ThcF or PirF and appropriate 
substrates and supplements at following concentrations: 50 mM Tris pH 8.0, 200 mM NaCl, 10 
mM MgCl2, 1 mM DTT, 2 mM DMAPP/GPP, 0.2 µM enzyme, and 0.5 mM peptide substrate 
(YYY, FFPP, FFPC, AcYYY, AcYLYDVLPGTK, AY, VY, or LY). The overnight reaction was 
quenched with 50% methanol. 10 µL of each reaction was subject to positive-ESI-LC/MS using 
Agilent 1200 Series HPLC with a Alltech Denali C18 column (5 µm, 120 Å, 4.6 mm × 250 mm) 
coupled to Agilent LC/MSD Ion Trap XCT Plus mass spectrometer. Mobile phases consisted of 
water with 0.1% formic acid (solvent A) and methanol with 0.1% formic acid (solvent B). The 
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expected product and residual peptide substrate were analyzed using a linear gradient of 5-100% 
B over 20 min at a flow rate of 0.75 mL/min and monitored with their corresponding masses 
under single ion mode. 
 
Results 
Co-crystal Structures of PagF with Substrates 
The broad substrate spectrum of cyanobactin prenyltransferases suggests they could 
prenylate any linear or cyclic peptide. In order to assess the structural determinants of substrate 
tolerance, we determined the crystal structures of native PagF (1.8 Å) and PagF in complex with 
prenyl donor analog dimethylallyl S-thiolodiphosphate (DMSPP) and boc-L-Tyr (2.1 Å), or Tyr-
Tyr-Tyr tripeptide (1.9 Å), or a cognate substrate cyclic[INPYLYP] (2.2 Å). The overall 
structure of PagF resembles the barrel architecture of the ABBA family of prenyltransferases 
with aromatic or indole-containing small molecules as substrates. It contains ten antiparallel β 
strands forming the inner face of the barrel and ten α helices surrounding outside (Fig. 4.2 A). 
Structural homology search of PagF against Protein Data Bank reveals prenyltransferases from 
the same family: fungal indole prenyltransferase FgaPT2 (PDB 3I4Z, RMSD 3.5 Å over 250 
aligned Cα) from Aspergillus fumigatus (Metzger, et al., 2009), bacterial aromatic 
prenyltransferase NphB (PDB 1ZCW, RMSD 3.3 Å over 236 aligned Cα) (Kuzuyama, Noel, & 
Richard, 2005) and CloQ (PDB 2XLQ, RMSD 3.5 Å over 216 aligned Cα) (Metzger, Keller, 
Stevenson, Heide, & Lawson, 2010) from Streptomyces species. The inner β barrel of PagF 
aligns decently with those of FgaPT2, NphB and CloQ, but the orientation of α helices is 
different. A second distinct strucutural feature of PagF is that the β barrel forms a solvent 
exposed channel with open bottom, yet the typical ABBA family small molecule 
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prenyltransferases block the bottom of the channel with either an α helix (NphB and CloQ) or 
loops with aromatic residues (FgaPT2) (Fig. 4.3 A-D). It suggests the channel of PagF stays in 
an open state in the absence of substrates, but to ensure productive catalysis and avoid undesired 
hydrolysis of prenyl donor, additional bulky structures have to be present to exclude solvent and 
close the bottom. 
Similar to typical ABBA family prenyltransferases, the active site of PagF is located in the 
channel. The co-crystal structures with different peptide substrates demonstrate that the binding 
of Tyr containing substrate blocks the bottom of the channel by pluging in the prenyl acceptor 
Tyr (Fig. 4.2 C, D). A hydrophobic environment is consequently created at the center of the 
channel for the dimethylallyl group of the prenyl donor. The diphosphate group of DMSPP is 
coordinated by R65, K136, H138, Y186, R288 and Mg2+ (Fig. 4.2 B). An active site divalent 
cation is typically required for prenylation reaction through coordinating the diphosphate 
oxygens and facilitating the formation of the electrophilic carbocation. Likewise, the function of 
cyanobactin prenyltransferases is dependent on the presence of Mg2+. Canonical 
prenyltransferases generally contain a characteristic (N/D)DxxD sequence motif for coordinating 
active site Mg2+, whereas Mg2+ binds in the active site of PagF without the signature motif. 
Lastly, the side chain of F222 also moves to avoid steric clash with DMSPP upon its binding. 
 
Substrate Binding Site of PagF 
A group of hydrophobic residues line the inner side of the PagF β barrel and create a 
hydrophobic environment to exclude solvent molecules from the active site channel. The 
placement of the substrate Tyr shields the environment and avoids unproductive quenching of 
the reactive intermediates. However, free amino acids are unable to completely close the channel. 
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A fairly large substrate is required to plug the bottom of PagF in a similar manner to the loops 
and helix at the bottom of the small molecule prenyltransferases. This provides the rationale for 
the observation that cyanobactin prenyltransferases only function on peptides or amino acids 
with bulky N-terminal modifications (Fig. 4.4 A-C). The carbonyl group of Tyr is in hydrogen-
bonding distance with R140. The residue immediately C-terminal to Tyr is secured by van der 
Waals interactions with Q190 and L220, which suggests aliphatic/aromatic residue is preferred at 
this position for an accepted substrate (Fig. 4.4 D). A hydrophobic wall consisting of Y269, 
W271 and Y292 interacts with the residues N-terminal to Tyr and creates a kink in the peptide 
substrate (Fig. 4.4 D). Interestingly, the Tyr favored at the active site in the co-crystal structure is 
the very N-terminal one for Tyr-Tyr-Tyr substrate but neither of the other two (Fig. 4.4 B). 
Similarly, the favored prenyl acceptor Tyr in the co-crystal structure with cyclic[INPYLYP] 
substrate is also the relatively N-terminal one immediately following Pro (Fig. 4.4 C). One 
possible explanation could be the aforementioned hydrophobic wall introduces steric hindrance 
for the positioning of the residues N-terminal to acceptor Tyr and thus limits the conformations 
that these residues have to adopt. But these conformations are not favored energetically. Implied 
from the preference of PagF over the residues N-terminal and C-terminal to Tyr, a linear peptide 
with the scaffold of a N-terminal Tyr immediately followed by an aliphatic/aromatic residue will 
be an effective substrate of PagF. 
Notably, the superimposition of the three co-crystal structures with the cyclic substrate or 
either of the two linear substrates reveals almost identical positioning of the prenyl acceptor Tyr, 
sandwiched between W271 on one side and L67 and F69 on the other side (Fig. 4.4 E). The 
phenolic oxygen of Tyr is coordinated by E51 at a distance of 2.6 Å and is likely deprotonated 
for the subsquent nucleophilic attack onto the dimethylallyl group. The C1 atom of dimethylallyl 
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group is located directly above the phenolic oxygen of Tyr at a distance of 3.1 Å and is therefore 
the favored atom for the reaction rather than the C3 atom, which otherwise would result in a 
reverse prenylation. Similar distances and substrate orientations have also been observed 
between the dimethylallyl C1 atom and reactive substrate atom in NphB and FgaPT2 active sites, 
with a distance of 4 Å and 3.1 Å, respectively (Kuzuyama, Noel, & Richard, 2005; Metzger, et 
al., 2009). The relative positioning of substrate Tyr and the dimethylally group indicates that the 
planar allylic carbocation resulted from the cleavage of DMAPP will be stabilized through 
cation-π interaction with the Tyr aromatic ring. 
 
Sequence Analysis of Cyanobactin Prenyltransferases 
Biochemical characterization of cyanobactin prenyltransferases demonstrated several 
members incapable of catalyzing prenylation reaction either in vivo or in vitro, such as PatF in 
pat pathway and TenF in ten pathway. tru pathway encodes two putative prenyltranferases TruF1 
and TruF2, but only the former one showed reverse prenylation activity. The reason for the 
catalytic deficiency of these prenyltransferases is still elusive but sequence comparison with 
active prenyltransferases might provide some clues. Primary sequence alignment of the 
cyanobactin prenyltransferases indicates that the key residues coordinating the diphosphate 
moiety of the prenyl donor in PagF co-crystal structures may play a crucial role in enzyme 
activity. In the characterized active prenyltransferases, the R65, K136, H138, Y186 and R288 (in 
PagF numbering) are highly conserved; in contrast, more than one of these residues are absent in 
the known inactive prenyltransferases (Fig. 4.5 A). In PatF, K136 is Met, H138 is Tyr, Y186 is 
Gly, and R288 is Cys. In TenF, R65 is Asp, H138 is Tyr, Y186 is Leu, and R288 is Ser. In 
TruF2, R65 is Gln, H138 is Ser, Y186 is Gly, and R288 is Leu. It seems that this diphosphate-
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binding motif signifies the catalytic capability or deficiency of a cyanobactin prenyltransferase. 
However, examination of either the primary sequences or the limited structural information on 
cyanobactin prenyltransferases didn’t provide much insight on the preference for forward or 
reverse prenylation or on the substrate selectivity. 
To gain more insights in sequence-function relationship, a Sequence Similarity Network of 
annotated standalone cyanobactin prenyltransferases was built based on all-by-all protein 
sequence BLAST results. The network was analyzed at the cutoff E-value of 1e-80 and proteins 
with higher sequence similarity cluster together (Fig. 4.5 B). All the known inactive 
prenyltransferases, PatF, TenF, and TruF2, cluster together, suggesting others in the same cluster 
might not be active as well. LynF and TruF1 appear as singletons in the network, which is 
consistent with their unique functions among all the characterized cyanobactin 
prenyltransferases. LynF is the only known prenyltransferase to catalyze reverse O-prenylation 
on Tyr to date; similarly, TruF1 is the only known one to catalyze the same reaction on Ser/Thr. 
The cluster where PagF is located potentially represents the ones catalyzing forward O-
prenylation on Tyr, but none except PagF has been investigated in vitro. PirF is encoded in the 
pir gene cluster from Microcystis aeruginosa PCC7005 and production of geranylated instead of 
prenylated cyanobactins has been detected (Fig. 4.1 A). It suggests PirF is an active 
geranyltransferase in vivo and the Tyr or Ser residue in the cyclic peptide is the potential site for 
geranyl group attachment (pir cluster lacks the heterocyclase gene for azoline ring installation 
and thus Ser is not modified) (Leikoski, Fewer, Jokela, Alakoski, Wahlsten, & Sivonen, 2012). 
Nevertheless, there are also examples with no reported in vivo prenyltransferase activity in this 
“active protein” cluster. For example, ThcF is encoded in cyanothecamide (thc) gene cluster but 
only unmodified cyclic cyanobactins were isolated despite the presence of Tyr residue available 
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for prenylation (Donia & Schmidt, 2011; Houssen, et al., 2012). Therefore ThcF is possibly 
inactive in vivo. As a consequence, a question mark is put on the function assignment of the 
protein cluster represented by PagF. 
 
Biochemical Characterization of ThcF and PirF Activity 
In order to assess the proposed Tyr prenylation activity of the protein cluster represented by 
PagF, the recombinantly expressed “inactive” ThcF and the “active” PirF were tested for 
prenylation/geranylation activity with a variety of peptide substrates and the modified products 
were monitored by LC/MS. In the presence of excess amount of Mg2+ and prenyl group donor 
DMAPP, ThcF is able to singly prenylate Tyr-Tyr-Tyr (YYY) tripeptide but doesn’t effectively 
attach the second prenyl group (Fig. 4.6). To verify that the only prenyl acceptor is the Tyr side 
chain hydroxyl group instead of the N-terminal α-amine, the Phe-Phe-Pro-Pro (FFPP) peptide 
was used for enzymatic assay to mimic a Tyr containing peptide with the reactive N-terminal α-
amine but not the side chain hydroxyl group. As expected, ThcF showed no activity towards α-
amine, indicating its substrate specificity towards Tyr containing peptide. Similarly, a Tyr-Tyr-
Tyr tripeptide with acetylated α-amine (AcYYY) was also successfully modified by ThcF, but at 
a considerably lower yield compared with the YYY tripeptide containing free α-amine, which 
indicates that possible steric hindrance introduced by the N-acetylation modification affects the 
accommodation of substrate peptide in the enzyme active site. The in vitro or in vivo activity of 
ThcF towards its native substrates wasn’t evaluated here to explain the detection of only 
unprenylated cyanobactins from the native producer. There is the possibility that the active site is 
not able to accommodate the size or the conformation of the native cyclic peptide substrate and 
this could be described as incomplete co-evolution of enzyme and its cognate substrates. A 
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second possibility is the prenylated cyanobactins were actually produced but only in small 
amount beyond the detection limit, or were lost during isolation process. 
The geranyltransferase activity of PirF was assayed with varied peptide substrates in a 
similar manner to ThcF and the modified products were monitored by LC/MS (Fig. 4.7). With 
excess amount of Mg2+ and geranyl diphosphate (GPP), PirF is able to effectively geranylate the 
YYY tripeptide. With GPP substituted by the C5 donor DMAPP in the activity assay, no 
modification was observed on the same tripeptide, which implies its strong selectivity towards 
isoprenoid group donor. To verify PirF catalyzes Tyr prenylation rather than N-prenylation on α-
amine, a Phe-Phe-Pro-Cys (FFPC) peptide substrate was tested with PirF and as predicted didn’t 
trigger geranylation reaction. A linear peptide Tyr-Leu-Tyr-Asp-Val-Leu-Pro-Gly-Thr-Lys with 
N-acetylation on α-amine (AcYLYDVLPGTK) was also successfully geranylated but with low 
conversion ratio. Similar to the observation in ThcF reaction, the extra structure N-terminal to 
the acceptor Tyr might introduce steric hindrance for proper substrate orientation in the active 
site. To access the effect of N-terminal structure on catalysis, PirF activity was evaluated against 
a panel of Tyr containing dipeptide with different N-terminal aliphatic residues. With Ala or Val 
N-terminal to the acceptor Tyr, PirF is able to completely convert the peptides in the assay 
condition. With Leu at N-terminus, the conversion ratio is significantly compromised, indicating 
a relatively inefficient catalysis by PirF. These results demonstrate that PirF catalyzes 
geranylation reaction on Tyr residue and the reaction is negatively affected by the bulky structure 
N-terminal to the acceptor Tyr. 
 
Structural Characterization of PirF 
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To gain structural insights on PirF, the crystal structure of native PirF is determined at a 
resolution of 2.46 Å. The overall structure of PirF resembles the barrel structure of the 
previously described PagF structure, composed of ten antiparallel β strands as the core of the 
barrel surrounded by ten α helices (Fig. 4.8 A). Residues spanning M1–S10 and F223–N229 
were not modeled in the structure due to the lack of electron density. The superimposition of 
PirF structure with PagF reveal the same topology and orientation of secondary elements (Fig. 
4.8 B). Similar to PagF, the central barrel of PirF also forms an open solvent-accessible channel 
with no auxiliary secondary structure blocking either end, suggesting the utilization of peptide 
substrate to plug the channel. The nearly perfect superimposition of PirF and PagF structures 
implies that the cyanobactin prenyltransferases are likely to use the same open-channel strategy 
to accommodate the bulky peptide substrates. Upon substrate binding, a closed hydrophobic 
environment is consequently created, free of solvent molecules and suitable for productive 
catalysis. 
Superimposition of PirF with PagF reveals that the residues coordinating the DMSPP and the 
acceptor Tyr are conserved in the active site channel of PirF. PirF residues R65, K134, H136, 
Y184 and R286 are located in the identical positions compared to their counterparts in PagF (Fig. 
4.9 A), suggesting their role in binding the diphosphate moiety of geranyl group donor GPP. The 
residues involved in binding the acceptor Tyr in PagF structure are also observed in similar 
positions in PirF structure (Fig. 4.9 B). M67 and F69 forms one side and W269 forms the 
opposite side. The acceptor Tyr is likely sandwiched between them similar to the Tyr 
coordination in PagF. PirF residue E51 is superimposable with the proposed active site base E51 
in PagF and is thus expected to deprotonate the acceptor Tyr to facilitate its nucleophilic attack 
onto the geranyl carbocation cleaved from the diphosphate. The similar residue arrangement of 
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PirF and PagF in the acceptor Tyr-binding site implies that this might be a characteristic 
organization of the active site for Tyr substrate. Scrutinization of the primary sequence showed 
that these residues are relatively conserved in the known Tyr cyanobactin prenyltransferases. In 
contrast, in TruF1, the only known Ser/Thr prenyltransferase to date, short polar residues appear 
at these positions. 
A distinct difference between PirF and PagF is that PirF strictly uses C10 isoprenoid donor 
(GPP) but not C5 donor (DMAPP). Therefore, a bigger pocket for the isoprenoid donor 
accommodation is expected in PirF compared to PagF. A close look at the hydrophobic residues 
in the vicinity of diphosphate coordination site led to a possible explanation for the preference of 
C10 isoprenoid donor (GPP).  Lack of the bulky F222 (PagF numbering) in PirF in conjunction 
with the outward twist of the β7 strand creates extra space in the active site channel (Fig. 4.9 C), 
which might favor the placement of geranyl group. This change is not resulted from missing the 
Phe in the primary sequence but caused by a Gly insertion before the Phe (Fig. 4.9 D). The Gly 
forces the succeeding Phe to face the outside of the barrel rather than introduce more steric 
hindrance inside the active site channel. However, this observation still could not perfectly 
answer why the C5 donor (DMAPP) is not accepted in a more spacious environment in PirF. It is 
possible there are other interactions between the geranyl group and the inner face of the barrel, 
which the smaller C5 could not fulfill. It is also possible that the C5 donor (DMAPP) does bind in 
the active site channel but it fails to prevent the solvent from quenching the reactive carbocation 
due to its smaller volume. In fact, this Gly insertion also appears in ThcF (Fig. 4.5 A), which is 
apparently active towards DMAPP (Fig. 4.6). Although ThcF wasn’t tested with GPP, the Gly 
insertion and the spacious environment are probably not the only determinants for the preference 
of isoprenoid donors. 
	   118	  
 
Discussion 
Cyanobactins adopt several strategies to increase their structure rigidity, stability and 
hydrophobicity, such as the heterocyclization of Ser/Thr/Cys, macrocyclization from a linear 
peptide and prenylation on the residual polar residues Ser/Thr/Tyr. While the heterocyclization 
and macrocyclization mainly increase the rigidity and resistance to nonspecific hydrolysis, 
prenylation with dimethylallyl or geranyl group considerably improves the lipophilicity. The 
involved enzymes, cyanobactin prenyltransferases, are among the few examples in bacteria that 
use peptides as substrate. Despite their independence of leader peptide, they do show high 
specificity towards the isoprenoid donor and the acceptor residue, making them potential tools 
for residue-specific prenylation with variable flanking sequences. 
To investigate the determinants of substrate specificity, co-crystal structures of 
prenyltransferase PagF with linear substrates or the native cyclic substrate were determined. The 
α/β barrel structure of PagF resembles the ABBA family aromatic prenyltransferases. But unlike 
the characterized small molecule ABBA prenyltransferases, the PagF barrel is fully solvent 
exposed with no blockage at either end. The structure of the piricyclamide geranyltransferase 
PirF presented here showed almost identical overall structure. It suggests that cyanobactin 
prenyltransferases share the same open-channel structure, consistent with their function as 
peptide prenyltransferase. The bulky peptide substrate serves as the plug of the open channel and 
assists in creating a hydrophobic environment for productive catalysis. Both the prenyl donor and 
acceptor are located inside the active site channel in PagF co-crystal structures. The diphosphate 
moiety of prenyl donor is coordinated through a hydrogen-bonding network from the polar side 
chains as well as the Mg2+, with dimethylallyl group positioned in a hydrophobic environment. 
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The peptide substrate is also harbored in a hydrophobic environment with the acceptor Tyr held 
in proximity to the dimethylallyl group. The Tyr stabilizes the carbocation intermediate through 
π-cation interaction with the dimethylallyl group cleaved from diphosphate. The phenolic oxygen 
of Tyr is located directly beneath the C1 atom of dimethylallyl group in PagF and the forward O-
prenylation is thus favored rather than the reverse prenylation. 
Sequence analysis of the annotated cyanobactin prenyltransferases supports the significance 
of the residues involved in substrate coordination and partially explains the substrate specificity. 
The diphosphate-binding residues identified in PagF co-crystal structures are also observed at 
identical positions in PirF and are highly conserved in the known active cyanobactin 
prenyltransferases. The substitution by other residues is found in all known inactive ones. The 
hydrophobic residues sandwiching the acceptor Tyr in PagF and potentially in PirF are only 
relatively conserved in Tyr prenyltransferases, consistent with their substrate specificity to Tyr 
containing peptides. These residues are replaced by short polar residues in TruF1, the only 
identified Ser/Thr cyanobactin prenyltransferase to date. These substitutions, probably together 
with other active site residues, establish a favorable local environment for Ser/Thr binding 
instead of the aromatic Tyr. The PagF residue E51 in hydrogen-bonding interaction with the Tyr 
phenolic oxygen appears in all active cyanobactin prenyltransferases and is likely the universal 
active site base for deprotonating hydroxyl group. The factors discriminating forward versus 
reverse prenylation remain elusive and unpredictable from primary sequence, but the relative 
orientation of the reactive oxygen and the isoprenoid donor might be an explanation. When the 
oxygen is located closer to the C1 atom of the dimethylallyl group, a forward prenylation occurs. 
Similarly, if the oxygen is in shorter distance to the C3 atom, a reverse prenylation is triggered. 
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The structures of PagF-substrate complexes and the activity assays for ThcF and PirF 
indicate that the Tyr cyanobactin prenyltransferases prefer peptide substrates with no bulky 
group immediately N-terminal to Tyr. Small protecting groups (such as boc and acetyl groups) 
and short aliphatic residues (such as Pro, Ala) are acceptable at the position N-terminal to Tyr. 
But substrates with bulkier substitutions are substantially blocked by the steric clashes in the 
substrate-binding tunnel. Consequently, the best peptide substrate seems to be one containing N-
terminal Tyr. This N-Tyr scaffold satisfies the chemoselectivity and regioselectivity of the Tyr 
cyanobactin prenyltransferases described here and could serve as a general guideline for 
designing peptide substrates for these enzymes. Since the Tyr cyanobactin prenyltransferases are 
selective towards only one residue and quite promiscuous to the rest of peptide sequence, they 
are better tools for introducing isoprenoid modifications in peptides compared to the protein 
prenyltransferases that recognize a four-residue sequence. 
With an increasing number of genomes sequenced from cyanobacteria, more cyanobactin 
prenyltransferases are discovered with varying substrate selectivity and are thus potential toolkit 
for introducing lipophilic isoprenoids to peptides. An example is the methyltransferase-
prenyltransferase fusion protein (MT-PT) in the biosynthetic gene clusters of short linear 
cyanobactins. These clusters encode the macrocyclase but the peptide products are not cyclic, 
possibly due to a peptide-length requirement for the macrocyclase to function properly. To 
increase the hydrophobicity of the peptide products and protect the N- and C- termini from 
nonspecific proteolysis, the MT-PT prenylates the N-terminal α-amine and methylates the C-
terminal carboxylate. This prenyltransferase domain is unique compared to the characterized 
standalone cyanobactin prenyltransferases, since it recognizes the α-amine instead of the residue 
side chains. Although the side chain of the N-terminal residue might still have to satisfy some 
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criteria, the specificity of this N-prenyltransferase to the backbone amine presents it as a 
promising tool for prenylating any peptide regardless of the sequence. 
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Figures 
 
 
 
Fig. 4.1    A. Representative cyanobactins. Patellamide A is produced by the pat gene cluster of 
Prochloron didemni and contains no isoprenoid modification. Aestuaramide A is produced by 
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the lyn gene cluster of Lyngbya aestuarii CCY9616. The dimethylally group on Tyr hydroxyl 
group is the product of reverse prenylation and is further spontaneously converted to forward 
prenylation on the carbon atom at meta position. Trunkamide is produced by the tru cluster of 
Prochloron didemni and contains reversely prenylated Ser and Thr. Prenylagaramide A is 
produced by the pag gene cluster of Oscillatoria agardhii and contains a forward-prenylated Tyr. 
Piricyclamide 7005E1 is produced by the pir gene cluster of Microcystis aeruginosa PCC7005. It 
contains modification with geranyl group but the residue for attachment is not determined. 
Aeruginosamide B is a linear cyanobactin isolated from Microcystis aeruginosa PCC9432 with 
reverse prenylation on N-terminal α-amine and methylation at C-terminus. B. Scheme for 
forward and reverse prenylation on Tyr. The side chain oxygen of Tyr attacks the C1 atom of 
dimethylallyl group to result in forward O-prenylation. The nucleophilic attack on C3 atom of 
dimethylallyl group leads to reverse O-prenylation in the case of LynF reaction. Subsequent 
nonenzymatic Claisen rearrangement generates the forward C-prenylated product. 
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Fig. 4.2    A. Overall structure of native PagF. The β strands (colored in olive) comprising the 
central barrel and the flanking α helices (colored in purple) are numbered separately. B. 
Coordination of prenyl donor analog DMSPP (green sticks) in the substrate-binding channel. The 
diphosphate moiety of DMSPP is coordinated by PagF residues shown as gray sticks. Mg2+ ion is 
shown as gray sphere. Hydrogen bonds are shown as black dashed lines. The Tyr (cyan) from 
prenyl group acceptor is in proximity to the dimethylallyl group. The Fo-Fc omit map showing 
the electron density of DMSPP is contoured at 2.4σ (blue) and 10σ (green). C. Longitudinal 
A B 
C D 
19	  Å 
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section of the PagF active site channel, showing the accommodation of both the prenyl donor 
analog DMSPP (green) and the native substrate cyclic[INPYLYP] (cyan). The peptide substrate 
blocks the bottom of the channel. Mg2+ ion is shown as gray sphere. D. Longitudinal section of 
the PagF active site channel, showing the inner surface (gray) of the channel. The widest point of 
the channel is around 19 Å and is blocked by the bulky peptide substrate. Prenyl donor analog 
DMSPP is shown as green sticks. Native substrate cyclic[INPYLYP] is shown as cyan sticks. 
Mg2+ ion is shown as gray sphere. 
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Fig. 4.3    A. A bird’s-eye view of the PagF barrel structure. The barrel forms a solvent-
accessible open channel. B. A bird’s-eye view of FgaPT2 barrel structure. The bottom of the 
barrel is blocked by hydrophobic loops. C. A bird’s-eye view of NphB barrel structure. The 
bottom of the barrel is blocked by an α helix. D. A bird’s-eye view of CloQ barrel structure. The 
bottom of the barrel is blocked by an α helix. 
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Fig. 4.4    A. A close view of the coordination of substrate boc-Tyr (cyan) in the substrate-
binding channel. B. A close view of the coordination of substrate Tyr-Tyr-Tyr (cyan) in the 
substrate-binding channel. C. A close view of the coordination of substrate cyclic[INPYLYP] 
(cyan) in the substrate-binding channel. D. A close view of the cyclic[INPYLYP] (cyan) 
substrate situated in the hydrophobic chamber. E. Superimposition of the Tyr containing 
substrates boc-Tyr (green), Tyr-Tyr-Tyr (cyan) and cyclic[INPYLYP] (purple) in the substrate-
binding channel. The prenyl acceptor Tyr residues align identically between L67, F69 and W271. 
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Fig. 4.5    A. Primary sequence alignment of representative annotated cyanobactin 
prenyltransferases. Residues coordinating diphosphate moiety of DMAPP in PagF structure are 
indicated with magenta arrowheads. B. Sequence Similarity Network (Gerlt, et al., 2015) of the 
A 
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annotated standalone cyanobactin prenyltransferases displayed at 1e-80 in Cytoscape (Shannon, 
et al., 2003). The PagF sequence was input into the EFI-EST server as the query sequence to 
achieve the all-by-all BLAST result of sequences sharing a similarity not less than 1e-5. The 
result was displayed in Cytoscape with a sequence-length limit set to avoid fragmented 
sequences or sequences from multi-domain proteins. The E-value was set to 1e-80 (30-40% 
sequence similarity) for further analysis. Nodes in the same cluster show higher sequence 
similarity to each other compared to the similarity to nodes outside the cluster. Representative 
nodes are labeled with the name of the protein. 
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Fig. 4.6    LC/MS analysis of the ThcF prenylation reactions. The protential prenyl accepting 
peptide YYY, FFPP or AcYYY is incubated with ThcF and excess amount of DMAPP 
overnight. The expected mono- and di- prenylated products as well as the starting material are 
analyzed with LC/MS. The blue trace represents the starting material left in the reaction mixture. 
The red trace represents the expected mono-prenylated product. The green trace shows the di-
methylated product. 
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Fig. 4.7    LC/MS analysis of the PirF geranylation reactions. The protential geranyl accepting 
peptide YYY, FFPC, AcYLYDVLPGTK, AY, VY or LY is incubated with PirF and excess 
amount of GPP overnight. The expected mono-geranylated product (red trace) is analyzed with 
LC/MS as well as the starting material left (blue trace) in the reaction mixure. PirF is also tested 
for prenylation activity with DMAPP and peptide YYY. 
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Fig. 4.8    A. Overall structure of native PirF. The β strands (colored in olive) comprising the 
central barrel and the flanking α helices (colored in gold) are numbered separately. B. Structural 
superimposition of PagF (purple) and PirF (gold). The central barrel of PirF forms a solvent-
accessible open channel as in PagF. 
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Fig. 4.9    A. Residues potentially coordinating the diphosphate moiety of GPP in the substrate-
binding channel of PirF. B. Superimposition of the residues involved in acceptor Tyr 
coordination in PagF (purple sticks) and the corresponding residues in PirF (pink sticks). C. 
Superimposition of the substrate-binding channel of PagF (purple) and PirF (gold). Residues for 
GPP coordination in PirF are shown as gray sticks. Hydrophobic residues at the opposite side are 
also shown as sticks. The counterpart of the PagF F222 is missing in PirF, causing a substantial 
outward twist of β7 strand in PirF. D. Sequence alignment of the β7 and β8 strands in PagF and 
PirF. The insertion of Gly at position 220 of PirF forces the side chain of the following F221 to 
face outside of the barrel. Its counterpart in PagF, F222, faces inside the barrel. 
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